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ABSTRACT 
The human brain is able to generate a wide repertoire of behavioral and psychological phenomena 
spanning from simple motor acts to cognition, from unimodal sensory perceptions to conscious 
experience. All these abilities are based on two key parameters of cortico-thalamic circuits 
functioning: the reactivity to a direct, local stimulation (cortical excitability) and the ability to causally 
interact (cortical effective connectivity). Indeed, alterations of these parameters have been 
suggested to underlie neurologic and psychiatric conditions. Over the last ten years, high-density 
electroencephalography combined with transcranial magnetic stimulation (TMS/hd-EEG) has been 
used to non-invasively probe cortical excitability and connectivity and to track over time 
pathological alterations, plastic changes and therapy-induced modifications in cortical circuits. 
A recently proposed theory suggests that consciousness depends on the brain’s ability to engage 
in complex activity patterns that are, at once, distributed among interacting cortical areas 
(integrated) and differentiated in space and time (information-rich). In a recent series of 
experiments the electroencephalographic TMS-evoked brain response was recorded in healthy 
subjects during wakefulness, non-rapid eyes movement sleep (NREM), under pharmacological 
conditions (anesthesia), and pathological conditions (severely brain-injured, vegetative state 
patients). Indeed, TMS/hd-EEG measurements showed that during wakefulness the brain is able to 
sustain long-range specific patterns of activation, while when consciousness fades in NREM sleep, 
anesthesia and vegetative state, the thalamo-cortical system produces either a local or a global 
slow wave which underlies respectively a loss of differentiation or integration.  
We hypothesize that, like spontaneous sleep slow waves, the slow waves triggered by TMS are 
due to bistability between periods of neuronal activity (up-state) and silence (down-state) in cortical 
networks. Thalamo-cortical bistability could impair the ability of thalamo-cortical circuits to sustain 
long-range, differentiated patterns of activation, a key theoretical requisite for consciousness. 
Animal studies show that the extracellular signature of the down-state is a transient suppression of 
high frequency (>20Hz) power in the local field potential (LFP). More recently, intracranial 
recordings during NREM sleep in humans have shown that a intracranial stimulations induce a 
 
iv 
 
widespread suppression of high frequencies (i.e. cortical down-states) that impair the ability of 
thalamo-cortical circuits to engage in causal interactions. 
In the present thesis we use a TMS/hd-EEG approach in patients affected by disorders of 
consciousness such as vegetative state (VS) and minimally conscious state (MCS) to investigate 
whether bistability could underlie also pathological loss of consciousness. To verify this hypothesis, 
we recorded TMS-evoked potentials (TEPs) in awake VS and MCS patients as well as in healthy 
controls (HC) during wakefulness and NREM sleep. TEPs were analyzed by means of time-
frequency analyses (power and phase-locking factor - PLF). We observed that TEPs recorded in 
VS patients were characterized by a large positive-negative deflection, closely resembling the one 
recorded in HC during NREM sleep. This sleep-like slow-wave was associated with a significant 
suppression of power in the high frequency band (>20 Hz) together with an early drop of PLF. 
Interestingly, in VS patients the power suppression slowly recovered to the baseline whereas in the 
NREM sleep of HC it was replaced by a late increase of power. Finally, the recovery of 
consciousness assessed in two patients evaluated longitudinally was paralleled by the resurgence 
of TEPs high frequency oscillations and by an increase of PLF duration. 
These results suggest that the slow waves evoked by TMS in VS patients possibly reflect a 
condition of cortical bistability that prevents the entrainment of thalamocortical modules in effective 
interactions and, hence, the emergence of consciousness. Intriguingly, the resumption of TEPs 
high frequency oscillations and a longer duration of phase-locked components (PLF) seem to be 
associated with the recovery of consciousness. Since bistability is, in principle, reversible and its 
mechanisms are well understood at the cellular and network level, it may represent a suitable 
target for novel therapeutic approaches in patients in whom consciousness is impaired, in spite of 
preserved cortical activity. 
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OUTLINE and MY CONTRIBUTION 
CHAPTER 1: in this chapter I briefly introduce the scientific problem of consciousness. According 
to theorethical and experimental neuroscience the human thalamo-cortical network is able to 
generate and sustain consciousness due to an optimal balance between functional integration and 
functional differentiation, otherwise defined as brain complexity. Here, cortical networks bistability 
is also introduced as a possible neurophysiological mechanism responsible for loss of 
consciousness (LOC) in physiological, pharmacological and pathological conditions. 
 
CHAPTER 2: in this section I present a well established perturb-and-measure approach aimed at 
non-invasively assess human cortical excitability and effective connectivity. The approach is based 
on a combination of transcranial magnetic stimulation and electroencephalography (TMS/EEG) 
and eventually lead to measure brain complexity in the human brain through the calculation of the 
Perturbational Complexity Index (PCI). 
Indeed, alterations of excitability and effective connectivity have been suggested to underlie 
neurologic and psychiatric conditions as shown in three studies that I have co-authored and that 
are presented in this chapter: 
• Casarotto S., Canali P., Rosanova M., Pigorini A., Fecchio M., Mariotti M., Lucca A., 
Colombo C., Benedetti F., Massimini M., “Assessing the effects of electroconvulsive 
therapy on cortical excitability by means of transcranial magnetic stimulation and 
electroencephalography.” Brain Topography (2013) 26:326–337. 
• Canali P., Sferrazza Papa G., Casali A.G., Schiena G., Fecchio M., Pigorini A., Smeraldi 
E., Colombo C., Benedetti F., “Changes of cortical excitability as markers of antidepressant 
response in bipolar depression: preliminary data obtained by combining transcranial 
magnetic stimulation (TMS) and electroencephalography (EEG).” Bipolar Disorders (2014) 
16: 809–819. 
• Canali P., Sarasso S., Rosanova M., Casarotto S., Sferrazza Papa G., Gosseries O., 
Fecchio M., Massimini M., Mariotti M., Cavallaro R., Smeraldi E., Colombo C., Benedetti 
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F., “Shared reduction of oscillatory natural frequencies in bipolar disorder, major depressive 
disorder and schizophrenia.” Journal of Affective Disorders 184 (2015) 111–115. 
Then, a review of a series of recent studies published by our group in which TMS/EEG has been 
employed to systematically measure excitability, connectivity and complexity of human cortical 
circuits in physiological (non-REM sleep), pharmacological (anesthesia) and pathological 
(vegetative state) LOC is presented.  
• Sarasso S., Rosanova M., Casali A.G., Casarotto S., Fecchio M., Boly M., Gosseries O., 
Tononi G., Laureys S., Massimini M., “Quantifying cortical EEG responses to TMS in 
(un)consciousness.” Clinical EEG and Neuroscience (2014) Vol. 45(1) 40–49. 
 
CHAPTER 3: in this section I propose a possible neurophysiological mechanism responsible for 
the collapse of brain complexity during LOC, firstly from an intracerebral perspective, then using 
TMS/EEG. 
Specifically, I first report a recent study where intracranial stimulation and recordings have been 
employed to measure cortical excitability in humans in wakefulness and NREM sleep. This study 
shows that when directly perturbed in wakefulness cortical circuits engage in sustained and 
deterministic electrical oscillations. On the contrary, during non-REM sleep cortical circuits respond 
to a direct perturbation with a neuronal silence (OFF-period or downstate) which impairs the ability 
of thalamo-cortical modules to engage in causal interactions. This bistability possibly disrupts the 
ability of the thalamocortical system to integrate information and to sustain consciousness.  
• Pigorini, A., Sarasso, S., Proserpio, P., Szymansky, C., Arnulfo, G., Casarotto, S., Fecchio, 
M., Rosanova, M., Mariotti, M., Lo Russo G., Palva, J.M., Nobili, L., Massimini, M., 
“Bistability breaks-off deterministic responses to intracortical stimulation during non-REM 
sleep”, NeuroImage 112 (2015) 105–113. 
In the second paragraph, I move from intracranial stimulations and recordings towards non-
invasive methodologies based on TMS/EEG. Thus, I present the main project of this thesis that 
stems from the results of the TMS/EEG approach applied in vegetative state patients. These 
results show that, similarly to non-REM sleep, vegetative state is characterized by cortical 
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bistability that, hence, could be an important common neurophysiological mechanism underlying 
both physiological and pathological LOC. 
This paragraph is focused on a recently submitted study: 
• Fecchio M., Rosanova M., Pigorini A., Sarasso S., Casarotto S., Seregni F., Gosseries O., 
Landi C., Casali A.G., Mariotti M., Trimarchi D., De Valle G., Laureys S., Massimini M., 
“Sleep-like cortical bistability in vegetative state patients”, submitted 
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CHAPTER 1 – INTRODUCTION 
It’s really hard define what consciousness is. It seems something obvious, something we take for 
granted, but we can be in trouble if someone ask us to define it, and we can try to say only when it 
disappears, when we don’t have experience of that. 
Consciousness is “what you lose on entering a dreamless deep sleep… deep anesthesia or 
coma… what you regain after emerging from these states” (Edelman, 2007) and we know that 
“every night, when we fall into dreamless sleep, consciousness fades, and reappears when we 
wake up or when we dream”(Tononi, 2008). 
During everyday life we assume that people around us are conscious, and, if in doubt, as when 
someone is resting with eyes closed, we can ask: if she/he answers that she/he was thinking or 
daydreaming, we infer she/he was conscious. But at times matters is not so clear: someone fast 
asleep shows no purposeful activity and will not respond to questions, yet she/he may be 
dreaming. Similarly, assess consciousness in some patients with severe brain injuries, with eyes 
open but unresponsive, may be not so straightforward and thus they can be judged clinically 
unconscious, even if they may be able to generate brain signals indicating they understood a 
question or a command (Cruse et al., 2011; Owen et al., 2006). In general, the problem is that 
while we assess the level of consciousness based on an individual’s ability to connect and respond 
to the external environment, these features are not necessary for consciousness. Yet, to this day, 
we do not have a scientifically well-grounded measure of the level of consciousness that is 
independent of processing sensory inputs and producing appropriate motor outputs. Nevertheless, 
neuroscience is making progress in identifying the neural correlates of consciousness. While many 
of the proposed neural substrates of consciousness undoubtedly have heuristic value, empirical 
evidence still does not provide criteria for necessity and sufficiency. For example, measurements 
performed during seizures (Blumenfeld and Taylor, 2003) where subjects are unconscious and 
unresponsive despite increased brain metabolism suggested that the overall levels of brain activity 
may not be a reliable marker of the presence of consciousness. Along the same lines, positron 
emission tomography (PET) measurements showed that brain-injured patients can recover 
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consciousness from vegetative state, without necessarily increasing their brain metabolic rates 
(Laureys et al., 2004). On the other hand, recent measurements have still focused attention on the 
hypothesis that the level of consciousness could be critically determined by the 
power/synchronization of spontaneous, fast frequency oscillations in the thalamocortical system. 
Indeed, this hypothesis fails to explain the loss of consciousness (LOC) observed during non-rapid 
eye movement (NREM) sleep, propofol anesthesia and generalized tonic-clonic seizures, where 
hyper-synchronous broad-band oscillations can be observed (Arthuis et al., 2009). As a 
consequence, even apparently simple questions like "why does consciousness fades during early 
NREM sleep?" and "why does it restores during dreaming?" have been (and still are) unanswered, 
thus pointing to the need of robust empirical studies complemented by a self-consistent, general 
and parsimonious theoretical approach (Sarasso et al., 2014).  
With the accumulation of empirical data, over the last decade theories of consciousness aimed at 
coherently account for experimental and clinical observations have been formulated. In particular, 
the Information Integration Theory of Consciousness (IITC), a recently proposed theory by Giulio 
Tononi (Tononi, 2008, 2004), suggests that consciousness depends not so much on the overall 
level of neuronal activation, on the occurrence of specific patterns of synchronous activity, or on 
the ability of cortical neurons to respond to sensory inputs, but rather on the joint presence of 
functional integration and functional differentiation in thalamo-cortical networks, otherwise defined 
as brain complexity (Massimini et al., 2012). Although integrated information can be measured 
exactly only in small simulated systems, the theory makes clear-cut predictions: integrated 
information should be high when consciousness is present and low whenever consciousness is 
lost. Practically, a straightforward way to gauge the conjoint presence of integration and 
information in real brains involves directly probing the cerebral cortex (to avoid possible subcortical 
filtering and gating) by employing a perturbational approach (thus testing causal interactions rather 
than temporal correlations) and examining to what extent cortical regions can interact as a whole 
(integration) to produce differentiated responses (information) (Sarasso et al., 2014). 
In the next chapter a noninvasive perturbation approach based on a combination of transcranial 
magnetic stimulation and electroencephalography (TMS/EEG) is presented to gauge the brain 
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capacity to integrate information. This technique allows stimulating directly different subsets of 
cortical neurons and recording the immediate reaction of the rest of the brain. As shown in 
paragraphs 2.2.1, 2.2.2 and 2.2.3, TMS/EEG is also used to estimate time-domain markers of 
biological cortical excitability and cortical effective connectivity, key parameters of cortico-thalamic 
circuits functioning. In paragraph 2.3, based on measurements performed in sleeping subjects 
(Massimini et al., 2007, 2005a), anaesthesia (Ferrarelli et al., 2010) and patients affected by 
disorder of consciousness (Rosanova et al., 2012) we argue that TMS/EEG represents an effective 
way to appreciate to what extent different regions of the thalamocortical system can interact 
globally (integration) to produce specific responses (information) and how it was possible 
developing a short index to measure the balance between information and integration and, 
possibly, the brain’s capacity for conscious experience.  
Finally, in the third chapter, after “understanding” how to distinguish a conscious brain from another 
one that is not and after trying to quantify the brain's capacity for conscious experience, the 
question that arises is "which is the mechanism underlying the loss of consciousness?". Here we 
propose a possible neurophysiological mechanism responsible for reducing interactions between 
different thalamocortical regions, firstly from an intracerebral perspective during deep sleep, and 
then using a noninvasive TMS/EEG approach in a pathological condition of loss of consciousness, 
the vegetative state patients. Indeed, during NREM sleep, bistability may be mainly caused by 
increased activity of leak K+ channels, brought about by decreased brainstem cholinergic activity 
(McCormick et al., 1993), however increased inhibition within thalamocortical networks may play a 
crucial role in inducing bistability (Mann et al., 2009). We suggest that bistability in thalamocortical 
networks, the key mechanism responsible for the occurrence of sleep slow waves, may also be 
what prevents the brain from effectively integrating information during physiological LOC. Due to 
bistability, cortical neurons are unable to sustain balanced patterns of activation and tend to fall 
into a silent, hyperpolarized down-state after an initial activation (Massimini et al., 2012). We 
hypothesize that also during pathological LOC bistability may prevent the emergence of 
consciousness making portions of the thalamocortical system, otherwise healthy, unable to sustain 
balanced pattern of activations. 
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As an example, a direct lesion of brainstem activating systems may cause bistability through the 
very same mechanisms governing NREM sleep. Specifically, brainstem lesions that reduce the 
cholinergic, noradrenergic, histaminergic and glutamatergic ascending drive may result in 
enhanced leak and depolarization dependent K+ currents in cortical neurons (McCormick et al., 
1993). Localized alterations, such as undetected cortical epileptic foci, can also exert a strong 
inhibitory drive on brainstem activating systems, thus producing diffuse cortical bistability (Englot et 
al., 2010). Alternatively, a form of bistability similar to the one observed during midazolam-induced 
LOC may result from cortical and subcortical lesions that alter the cortical balance between 
excitation and inhibition in favor of inhibition. For instance, recovery of language and motor function 
after stroke can be blocked by excessive inhibitory activity in the perilesional area; (Classen et al., 
1997) this excessive inhibition may be generated locally or may be projected by healthy areas that 
become hyperactive (Murase et al., 2004). Thus, cortical lesions that, by themselves, would not 
necessarily impair consciousness may induce LOC by causing a general unbalance between 
excitation and inhibition in healthy portions of the thalamocortical system. An excess of 
thalamocortical inhibition from a hyperactive, subcortical inhibitory area could also explain the 
paradoxical effects of the sedative zolpidem, a nonbenzodiazepine hypnotic that potentiates 
GABAA receptors, on behavioral improvement of alertness and interactive behavior in severely 
brain-injured patients (Brefel-Courbon et al., 2007; Schiff, 2010; Whyte and Myers, 2009) .Another 
crucial event that may induce bistability following brain injury is cortical deafferentation. Severing 
the white matter with a cortical undercut results in slow waves and in a continuous alternation 
between up- and down-states in the partially deafferented gyrus, even when the animal and the 
rest of the brain are awake (Nita et al., 2007). 
In all cases, evaluating the presence of bistability in the cerebral cortex of brain-injured patients is 
critically important. Indeed, while anatomical lesions and disconnections cannot be reversed, it 
may still be possible to reduce bistability and functional disconnections by acting pharmacologically 
on intrinsic neuronal properties (Sarasso et al., 2014). 
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CHAPTER 2 – EMPLOYING TMS/EEG TO MEASURE CORTICAL 
REACTIVITY IN HEALTHY SUBJECTS, PSYCHIATRIC AND 
NEUROLOGICAL PATIENTS 
Different methods have been proposed in order to infer on a subject’s level of consciousness solely 
based on brain activity. Some of these methods, such as spectral analysis (Berthomier et al., 2007) 
and the proprietary ‘bispectral index’ (Myles et al., 2004) seem to correlate empirically with 
consciousness but have no clear theoretical foundation. Other measures, such as neural 
complexity (Tononi, 2004) and causal density (Seth, 2005), are theoretically motivated (Seth et al., 
2008) but have not yet been tested empirically. More or less explicitly, all these measures attempt 
to capture the coexistence of functional integration and functional differentiation in spontaneous 
(mainly EEG) brain signals. Yet, to dependably appreciate the brain’s capacity for consciousness 
(defined as integrated information) one should go beyond spontaneous activity levels or patterns of 
temporal correlation among distant neuronal groups (functional connectivity). First, this is because 
the repertoire of available states is, by definition, potential and, thus, not necessarily observable. 
Second, because it is difficult to say whether a system is actually integrated or not by just 
observing the spontaneous activity it generates (Massimini et al., 2009). Indeed, the ability to 
integrate information can only be demonstrated from a causal perspective; one must employ a 
perturbational approach (effective connectivity) and examine to what extent subsets of neurons 
can interact causally as a whole (integration) to produce responses that are specific for that 
particular perturbation (information) (Massimini et al., 2009). Moreover, one should probe causal 
interactions by directly stimulating the cerebral cortex in order to avoid possible subcortical filtering 
or gating. Finally, since causal interactions among thalamocortical neurons develop on a sub-
second time scale (just as phenomenal consciousness does), it is very important to record the 
neural effects of the perturbation with the appropriate temporal resolution.  
Thus, in practice, one should find a way to stimulate different subsets of cortical neurons and 
measure, with good spatial-temporal resolution, the effects produced by these perturbations in the 
rest of the thalamocortical system. Today, this measurement can be performed non-invasively in 
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humans thanks to the development of a novel electrophysiological technique, based on the 
combination of  TMS and hd-EEG (Ilmoniemi et al., 1997) (Figure 2.1).  
 
 
Figure 2.1 - TMS/EEG setup. In this example, a subject is sitting on an ergonomic chair while TMS is targeted to 
the occipital cortex. The red arrows indicate, from left to right, the three fundamental elements that compose the 
set-up: (1) a cap for high-density (60 channels) EEG recordings (hd-EEG) that is connected to a TMS-compatible 
amplifier; (2) a focal figure-of-eight stimulating coil (TMS), held in place by a mechanical arm; (3) the display of 
the navigated brain stimulation system (NBS). This system employs an infrared camera (not visible in this 
picture) to navigate TMS on a 3D reconstruction of the subject’s MRI. The location and the intensity of the 
electric field induced by TMS are estimated and displayed in real time. To prevent the subject from perceiving 
the click associated with the coil’s discharge, noise masking is played through inserted earplugs. 
 
With TMS, the cerebral cortex is stimulated directly by generating a brief but strong magnetic pulse 
(<1 ms, 2 Tesla) through a coil applied to the surface of the scalp. The rapid change in magnetic 
field strength induces a current flow in the tissue, which results in the activation of underlying 
neuronal populations. The synchronous volley of action potentials thus initiated propagates along 
the available connection pathways and can produce activations in target cortical regions. By 
integrating TMS with MR-guided infrared navigation systems, it is also possible to render the 
perturbation controllable and reproducible, in most cortical regions. Finally, using multi-channel 
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EEG amplifiers that are compatible with TMS (Virtanen et al., 1999) one can record, starting just a 
few milliseconds after the pulse, the impact of the perturbation on the stimulated target and in 
distant cortical areas. Indeed, the integrated use of neuro-navigation systems, TMS and 
multichannel TMS-compatible EEG amplifiers together constitute a new brain scanning method in 
which stimulation is navigated into any desired brain target and the concurrently recorded scalp 
potentials are processed into source images of the TMS-evoked neuronal activation (Komssi and 
Kähkönen, 2006). 
It is worth highlighting some of the specific advantages that TMS/EEG may offer as a tool to probe 
the brain: 
1) TMS-evoked activations are intrinsically causal (Paus, 2005). Thus, unlike methods 
based on temporal correlations, TMS/EEG immediately captures the fundamental 
mechanism that underlies integration, that is the ability of different elements of a system 
to affect each other.   
2) TMS/EEG by-passes sensory pathways and subcortical structures to probe directly the 
thalamocortical system. Therefore, unlike peripherally evoked potentials and evoked 
motor activations, TMS/EEG does not depend on the integrity of sensory and motor 
systems and can access any patient (deafferentated or paralyzed). Moreover, with TMS 
one can stimulate most cortical areas (including associative cortices) employing several 
different parameters (intensity, angle, current direction), thus probing a vast repertoire of 
possible responses, above and beyond observable ongoing brain states. 
3) TMS-evoked potentials can be recorded with millisecond resolution, a time scale that is 
adequate to capture effective synaptic interactions among neurons. 
4) TMS/EEG does not require the subject to be involved in a task and the observed 
activations are not affected by the willingness of the subject to participate nor by his 
effort and performance. Hence, this approach is well suited to assess the objective 
capacity of thalamo-cortical circuits independently on behavior. 
 
8 
 
5) TMS/hd-EEG can be made portable in order to overcome the logistical and economic 
hurdles that may separate severely brain-injured patients from advanced imaging 
facilities. 
Thus, at least in principle, TMS/EEG may represent an appropriate tool to approximate a 
theoretical measure of consciousness not only in healthy subjects, but above all at the patient’s 
bedside. However, the question whether this technique may actually detect changes in the brain’s 
capacity to integrate information can only be answered experimentally. For example, one should 
demonstrate that TMS-evoked activations are widespread (integration) and specific (information) in 
a conscious brain but that they become either local (revealing a loss of integration) or stereotypical 
(revealing a loss of information) when the same brain becomes unconscious. In this chapter we 
first describe methodological aspects of TMS/EEG data analysis and then we describe the results 
of experiments where TMS/EEG was used to understand what changes in human thalamo-cortical 
circuits when consciousness fades upon falling asleep, during anesthesia and in pathological 
conditions (disorder of consciousness). 
2.1 – TMS/hd-EEG Recording 
2.1.1 – TMS Targeting 
A Focal Bipulse 8-Coil (mean/outer winding diameter ca. 50/70 mm, biphasic pulse shape, pulse 
length ca. 280 µs, focal area of the stimulation hot spot 0.68 cm2) driven by a Mobile Stimulator 
Unit (Eximia TMS Stimulator, Nexstim Ltd., Helsinki, Finland) was targeted to specific cortical 
locations using a Navigated Brain Stimulation (NBS system (Nexstim Ltd., Helsinki, Finland). 
Structural MRI images at 1 mm3 spatial resolution were acquired with a 1T Philips scanner from all 
subjects enrolled in the studies. The NBS system employs a 3D infrared Tracking Position Sensor 
Unit to map the positions of TMS coil and subject’s head within the reference space of individual 
structural MRI in order to precisely identify the TMS stimulation target. Optimal alignment between 
MRI fiducials and digitized scalp landmarks (nasion, left and right tragus) was verified prior to all 
experiments. NBS also calculates on-line the distribution and intensity of the intracranial electric 
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field induced by TMS, using a best-fitting spherical model of subjects’ head and brain and taking 
into account the exact shape, 3D position and orientation of the coil. TMS hot spot (i.e. 98% of the 
maximum stimulating electric field calculated at individually-determined depth) was kept fixed to 
the stimulation target with the current perpendicular to its main axis. The reproducibility of the 
stimulation coordinates across sessions was guaranteed by an aiming device that indicated in real-
time any deviation from the desired target greater than 3 mm. 
2.1.2 – hd-EEG Recording 
TMS-evoked potentials were recorded by a TMS-compatible 60-channel EEG amplifier (Nexstim 
Ltd., Helsinki, Finland). Impedance at all electrodes was kept below 5 kΩ. The EEG signals, 
referenced to an additional electrode on the forehead, were filtered (0.1-500 Hz) and sampled at 
1,450 Hz with 16 bit resolution. At the end of each experiment, a pen visible to the infrared camera 
was used to digitise the EEG electrode positions on the subject’s head. Two extra electrodes were 
used to record the vertical electrooculogram (EOG).  
During EEG recording, subject’s perception of the clicks produced by TMS coil’s discharge was 
eliminated by means of inserted earplugs continuously playing a masking noise (always below 90 
dB). A thin layer of foam was placed between coil and scalp (resulting in less than 1 mm thickness 
when coil was pressed against the head) in order to attenuate bone conduction. As previously 
demonstrated, this procedure effectively prevented any contamination of EEG signals by auditory 
potentials elicited by TMS-associated clicks (Massimini et al., 2007, 2005a).  
2.1.3 – EEG Pre-processing 
Trials containing activity from other sources than neural were automatically rejected if EOG 
exceeded 70 μV (ocular activity) and/ or absolute power of EEG channel F8 in the fast beta range 
(N25 Hz) exceeded 0.9 μV2/Hz (van de Velde et al., 1998)(indicating activity of fronto-temporal 
muscles). After averaging, channels with bad signal quality or large residual artifacts were 
excluded from further analysis. In all TMS sessions we retained at least 50 good channels, with an 
inter-session variation of at most 4 channels in each subject, thus ensuring an estimation of cortical 
 
10 
 
generators that was reliable and comparable across sessions (Laarne et al., 2000). Signals were 
low pass ﬁltered (45 Hz), down-sampled to 725 Hz and re-referenced to the common average 
reference. Independent component analysis (ICA) was performed in order to remove the remaining 
artefacts. Figure 2.1.1A exhibits an example of pre-processed single-subject TMS-evoked 
potentials after stimulation of BA19. 
 
Figure 2.1.1 - Single-subject TMS-evoked potentials. A) Top Left: Location of the TMS stimulation target (left 
superior occipital lobule, BA 19) is shown on individual MRI, together with the approximate distribution of the 
electric field induced by TMS pulses in the cortex. The orange spots represent the digitized positions of EEG 
electrodes on the scalp. Right: Averaged TMS-evoked potentials recorded from 60 electrodes on the scalp at 
three different intensities of stimulation (red 118V/m, blue 84V/m, black 49V/m). Approximate location of the TMS 
target is reported with a red circle. Bottom left: zoom on averaged EOG activity, TMS-evoked potentials recorded 
on PO3 lead, and also during a sham TMS session, when the TMS coil was discharged while separated from the 
scalp by a 4 cm Plexiglas cube.  B) Superimposition of the averaged TMS-evoked potentials recorded from all 
channels (Butterfly plot) at a stimulation intensity of 118V/m. Color-coded instantaneous topographic 
distribution of the potential on the scalp is displayed for 7 relevant time samples after TMS pulse delivery. 
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2.2 – TMS/EEG to assess key parameters of human cortical circuits 
functioning  
Despite a highly static structure, the human brain generates a large repertoire of behavioral and 
psychological phenomena spanning from simple motor acts to cognition and consciousness. This 
ability relies on the activation of highly specialized thalamic and cortical structures that interact on a 
subsecond timescale by means of long-range bundles of fibers (Park and Friston, 2013; Sporns, 
2013). Hence, the electrical reactivity of the cerebral cortex to a direct, local stimulation (cortical 
excitability) and the ability of distant cortical regions to causally interact (cortical effective 
connectivity) are key parameters of cortico-thalamic circuits functioning. Since recently, by 
combining navigated TMS with EEG (TMS/EEG), it is possible to record the immediate response of 
the human brain to a cortical perturbation. In this way, TMS/EEG allows to measure directly and 
non-invasively changes of cortical excitability and effective connectivity occurring in physiological, 
pharmacological and pathological conditions (Ziemann et al., 2015). 
In the following paragraphs, three different studies are reported, showing the application of 
TMS/EEG to estimate time-domain markers of biological excitability and connectivity. 
Specifically: 
• paragraph 2.2.1 is referred to the paper titled “Assessing the Effects of Electroconvulsive 
Therapy on Cortical Excitability by Means of Transcranial Magnetic Stimulation and 
Electroencephalography” by Casarotto et al., 2013 published on Brain Topograpghy. 
• paragraph 2.2.2 is referred to the paper titled “Changes of cortical excitability as markers of 
antidepressant response in bipolar depression: preliminary data obtained by combining 
transcranial magnetic stimulation (TMS) and electroencephalography (EEG)” by Canali et 
al., 2014 published on Bipolar Disorders. 
• paragraph 2.2.3 is referred to the paper titled “Shared reduction of oscillatory natural 
frequencies in bipolar disorder, major depressive disorder and schizophrenia” by Canali et 
al., 2015 published on Journal of AffectiveDisorders. 
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2.2.1 – Assessing the Effects of Electroconvulsive Therapy on Cortical Excitability 
by Means of Transcranial Magnetic Stimulation and Electroencephalography 
Electroconvulsive therapy (ECT) is generally recommended to drug-resistant patients suffering 
from severe major depression, because of its significant short-term antidepressant effects (UK 
ECT Review Group, 2003). The mechanism of action of ECT still needs to be fully characterized, 
although several hypotheses have been conceived, involving neurotransmitter systems (Yatham et 
al., 2010), endocrinological pathways (Kunugi et al., 2006), and neurogenesis (Madsen et al., 
2000; Nibuya et al., 1995). 
In animals, electroconvulsive seizures (ECS) have several effects on synaptic plasticity, gene 
transcription, and cell proliferation. ECS induces potentiation-like long-lasting synaptic changes 
(Stewart et al., 1994), increases the expression of neurotrophins, especially brain-derived 
neurotrophic factor (BDNF), and thus the activation of their receptor tyrosine kinase B (TrkB) (Altar 
et al., 2004; Nibuya et al., 1995) and stimulates the proliferation of neuronal and glial cells in the 
frontal cortex and hippocampus (Madsen et al., 2004; Malberg et al., 2000; Perera et al., 2007) of 
rats and nonhuman primates. BDNF/TrkB receptors promote neuronal function, growth and 
regeneration (Mamounas et al., 1995) and are mainly located at glutamatergic synapses, where 
they trigger synaptic potentiation and serve as activity-dependent modulators of synaptic plasticity 
(Mattson, 2008; Minichiello, 2009). Glial cells are also involved in the glutamatergic 
neurotransmitter system, by providing energy to neurons and releasing neurotrophic factors (Ben 
Achour and Pascual, 2010). 
On the other hand, clinical studies have associated stress and depression with atrophy and loss of 
neurons and glia, especially in the prefrontal cortex and hippocampus (Duman and Voleti, 2012; 
Salvadore et al., 2011). An abnormally reduced expression of BDNF/TrkB has been observed in 
the frontal cortex and hippocampus of suicide patients (Dwivedi Y et al., 2003). Moreover, 
depressive symptoms have been correlated with dysfunction of the prefrontal cortex (George et al., 
1994), particularly concerning its relationship with limbic structures implicated in the regulation of 
mood and anxiety (Drevets, 2000; G E Alexander et al., 1986; Suwa et al., 2012). 
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The existence of a causal relationship among depression, plasticity and neurotrophins proposed by 
previous literature (Manji et al., 2001; Zarate et al., 2003) has encouraged to explore the 
modulation of motor cortex excitability induced by ECT in humans (Bajbouj et al., 2006, 2005; 
Chistyakov et al., 2005; Sommer et al., 2002). The results of these studies are not conclusive, 
since cortical excitability was found to be either decreased (Bajbouj et al., 2006, 2005; Sommer et 
al., 2002) or increased (Chistyakov et al., 2005) after treatment as compared to baseline. However, 
two of these studies (Bajbouj et al., 2005; Sommer et al., 2002) referred to single cases and all of 
them used the peripheral muscular responses to transcranial magnetic stimulation (TMS) of the 
primary motor cortex to estimate cortical excitability. 
Today, a complementary, direct measure of cortical excitability in humans can be obtained non-
invasively by means of transcranial magnetic stimulation combined with electroencephalography 
(TMS/EEG) (Ilmoniemi et al., 1997; Komssi and Kähkönen, 2006; Ziemann, 2011). This approach 
allows to directly perturb cortical regions and to record the immediate electrophysiological 
responses of the stimulated neurons. Most important, TMS-evoked potentials (TEPs) are 
characterized by high test–retest reproducibility, provided that stimulation parameters (site, 
intensity and angle) are accurately controlled across subsequent sessions by means of a magnetic 
resonance (MR)-guided navigation system (Casarotto et al., 2010). Hence, TMS/EEG has been 
successfully applied to detect, at the group level, cortical excitability changes induced by repetitive 
TMS (rTMS) in healthy individuals (Esser et al., 2006; Veniero et al., 2010). In these cases, the 
local synaptic potentiation deliberately induced in the motor cortex by high-frequency rTMS was 
measured as an increase of the amplitude of early TMS-evoked EEG responses between 0 and 80 
ms (Esser et al., 2006; Veniero et al., 2010). Similarly, a recent TMS/EEG study (Huber et al., 
2013) has allowed to detect a physiological increase of cortical excitability with time awake, that 
became significant at the single-subject level after one night of sleep deprivation. 
In this work, we employ TMS/EEG to study the electrophysiological changes induced by ECT in 
human cortical circuits. Thus, we measured the changes in the immediate EEG response to TMS 
of the frontal cortex before and after a course of ECT. The aim of this study was to contribute to the 
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understanding of the electrophysiological mechanisms of ECT in the human brain and to evaluate 
novel tools for monitoring and guiding neuromodulation protocols for the treatment of depression. 
2.2.1.1 Materials and Methods 
The experimental protocol involved two TMS/EEG recording sessions for each patient, that were 
performed, respectively, the day before the first administration of ECT (pre-ECT) and the day after 
the last administration of ECT (post-ECT), early in the afternoon at about 3:00 pm. The same 
stimulation parameters were applied to each patient in both sessions. 
Participants 
Eight inpatients suffering from Major Depressive Disorder, as diagnosed according to the DSM-IV 
criteria, participated in this study (Table 2.1). Physical examination, laboratory tests and 
electrocardiograms were performed at admission. All patients were referred to ECT because they 
were drug-resistant, i.e. showed a lack of improvement to at least two different treatments with 
antidepressants, at adequate dosage and duration (>6 weeks) (Fava, 2003). No patient had 
received ECT within 6 months prior to study enrolment. Additional diagnosis on axis I besides 
major depression, mental retardation on axis II, history of drug/alcohol abuse or dependency, and 
major medical/neurological disorders were regarded as exclusion criteria. In addition, patients with 
medical history of seizures, convulsions, loss of consciousness and traumatic brain injury, carriers 
of intracranial metallic objects and/or of cardiac pace-makers were excluded to prevent potential 
adverse effects of TMS. Severity of the current major depression episode was rated on the 21-item 
Hamilton Depression Rating Scale (HDRS) (Hamilton, 1960), administered by a qualified 
psychiatrist. HDRS was assessed at baseline, after each ECT session, and at the end of the whole 
treatment. All patients were properly acquainted with the experimental procedures (Mini-Mental 
State Examination was always above 26) before signing a written informed consent to 
participation. Moreover, we explicitly reassured them about the possibility of interrupting the 
experiment upon any unpleasant feeling. The study was approved by the Local Ethical Committee. 
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Table 2.1 - Demographic characteristics 
Patient Gender 
Age 
(years) 
Age of onset 
of depression 
Family 
history 
n° 
previous 
episodes 
Duration 
current 
episode 
(months) 
Concurrent 
drug 
treatment 
1 F 54 50 No 2 16 TCA,NL 
2 M 42 28 No 2 24 TCA 
3 F 60 57 No 1 24 TCA 
4 M 53 31 Yes 2 36 TCA 
5 F 44 15 Yes 3 6 SNRI 
6 F 51 35 Yes 2 24 TCA 
7 F 61 41 Yes 7 7 SNRI 
8 F 51 39 Yes 3 12 SNRI 
F female, M male, SNRI serotonin norepinephrine reuptake inhibitors, TCA tricyclics, NL neuroleptics, SSRI selective 
serotonin reuptake inhibitors 
 
ECT Delivery 
ECT was administered twice a week with bilateral electrode placement (spECTrum 5000Q®, 
MECTA, Tualatin, OR, USA). Two circular flat electrodes (diameter: 5.08 cm) were positioned on 
both sides of the head with midpoints approximately 2.54 cm above the center of a line connecting 
the tragus and the external canthus. Current was delivered through trains (duration: 1.39 ± 0.13 s) 
of rectangular, constant-current pulses (amplitude: 800 mA) with alternating polarity (pulse width: 
1.41 ± 0.12 ms; pulse pairs per second: 57.36 ± 7.36 Hz). The dose titration method for eliciting 
adequate seizures and other technical parameters were established according to (American 
Psychiatric Association. Task Force on Electroconvulsive Therapy.2001). Brief general anesthesia 
was induced with thiopental (i.v. 5 mg/kg) and succinylcholine (i.v. 1 mg/kg) for relaxation. In 
addition, pre-medication with atropine (i.m. 0.5 mg/kg) was used to reduce the risk of vagal 
immediate bradyarrhythmia or asystole. Each patient was administered a variable number of ECT 
sessions, according to the individual clinical needs evaluated by experienced clinicians (Table 2.2). 
Each patient was carefully evaluated by qualified psychiatrists throughout the whole ECT protocol, 
in order to monitor the therapeutic and cognitive effects of treatment. In particular, ECT was 
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administered until remission of depressive symptoms (at least 50 % reduction of HDRS score as 
compared to pre-ECT assessment) or onset of unwanted side effects pertaining cognitive 
functions. 
 
Table 2.2 - Clinical and neurophysiological effects of ECT 
Patient 
n° ECT 
sessions 
HDRS IRA (μV2) IRS (μV/ms) 
Pre- 
ECT 
Post- 
ECT 
p 
Pre- 
ECT 
Post- 
ECT 
p 
Pre- 
ECT 
Post- 
ECT 
p 
1 8 38 18  47 58 .034 0.57 0.80 .006 
2 7 27 13  74 82 .014 0.76 1.07 .000 
3 3 22 3  57 75 .020 0.64 0.67 .771 
4 8 20 12  9 18 .026 0.04 0.46 .004 
5 7 25 16  132 196 .002 0.21 0.52 .000 
6 9 19 12  14 23 .010 0.09 0.14 .268 
7 5 25 2  9 21 .002 0.15 0.31 .000 
8 3 19 3  24 33 .024 0.36 0.37 .717 
Mean 
± SE 
6.3 
± 0.82 
24.4 
± 2.22 
9.9 
± 2.23 
.025 
45.7 
± 14.94 
63.2 
± 20.90 
.025 
0.35 
± 0.1 
0.54 
± 0.11 
.025 
SE standard error, ECT electroconvulsive therapy, HDRS Hamilton Depression Rating Scale, IRA immediate response 
area, IRS immediate response slope 
 
TMS/EEG Recording 
TMS was delivered with a Focal Bipulse 8-Coil (mean/outer winding diameter ca. 50/70 mm, 
biphasic pulse shape, pulse length ca. 280 μs, focal area of the stimulation hot spot 0.68 cm2; 
Eximia TMS Stimulator, Nexstim Ltd., Helsinki, Finland). Stimulation parameters were controlled by 
means of a Navigated Brain Stimulation (NBS) system (Nexstim Ltd., Helsinki, Finland), that 
employs a 3D infrared Tracking Position Sensor Unit (Polaris, Northern Digital Inc., Waterloo, 
Canada) and integrates T1-weighted structural MR images recorded from all patients (3.0 tesla 
scanner, Intera, Philips Medical Systems, Best, The Netherlands; 0.9 × 0.9 × 0.8 mm spatial 
resolution). This equipment maps in real time the positions of TMS coil and subject’s head within 
the reference space of individual MR images by aligning the fiducials selected on structural images 
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with the corresponding digitized scalp landmarks (nasion, left and right tragus). The NBS system 
(Ruohonen and Ilmoniemi, 1999; Ruohonen and Karhu, 2010) allowed (i) to precisely stimulate a 
cortical target selected a priori on individual MR images, (ii) to estimate the electric field (EF) 
induced on the cortical surface by TMS pulses, and (iii) to accurately repeat the same stimulation 
parameters between sessions. The induced EF clearly depends on stimulation intensity, expressed 
as percentage of the maximal stimulator output, on the relative position between subject’s head 
and TMS coil, and on the geometrical and physical properties of head tissues between the 
stimulator and the cortical surface. The distribution and intensity (expressed in V/m) of the 
intracranial induced EF was estimated on-line using a locally best-fitting spherical model of the 
subjects’ head and brain and taking into account the exact shape, 3D position and orientation of 
the TMS coil. Precise control over stimulation coordinates across sessions was obtained by means 
of a virtual aiming device, that displayed in real time on a screen any deviation from the desired 
target greater than 3 mm and therefore allowed manual adjustments of the stimulator position. 
The middle-caudal portion of the superior frontal gyrus close to the midline (near the boundary 
between Brodmann areas 6 and 8) was selected as target area. Indeed, the prefrontal cortex is 
maximally involved by current flow during bilateral ECT (Boylan et al., 2001; Lee et al., 2012) and 
its metabolic activity is significantly modulated by treatment (Nobler et al., 2000; Suwa et al., 2012). 
Moreover, this targeting ensured maximal distance from cranial muscles, which are mainly 
distributed over the lateral surface of the scalp and whose unwanted activation by TMS would 
affect EEG recordings. TMS pulses were delivered to the target area nearby the mid-sagittal plane: 
however, since TMS is not suited to properly stimulate along the longitudinal fissure (Thielscher et 
al., 2011), the coil was slightly moved either towards the left or the right side of the head in order to 
better deliver TMS pulses on the convexity of the middle-caudal portion of the superior frontal 
gyrus, with the current perpendicular to its main axis. Patients were randomly divided into two 
groups of equal size for being predominantly stimulated either on the left (four patients) or right 
(four patients) hemisphere. This protocol was applied to obtain a comparable amount of data from 
stimulation of both hemispheres in a small group of patients, in the lack of a priori assumptions 
about laterality of the effects of bilateral ECT. Moreover, this approach allowed to shorten the 
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duration of TMS/EEG sessions, thus limiting any additional stress to patients. Two patients were 
particularly collaborative and therefore agreed to being stimulated on both hemispheres. Excitation 
threshold has been reported to change with cortical location (Boroojerdi et al., 2002; Gerwig et al., 
2003; Stewart et al., 2001); moreover, we specifically delivered TMS pulses over the prefrontal 
cortex. Therefore, we set stimulation intensity relying on the actual intracranial induced EF 
estimated by the NBS system rather than referring to the minimum stimulator output needed to 
produce a reliable electromyographic response (motor threshold; Rossi et al., 2009). In all patients, 
the maximum EF induced by TMS on the cortical surface was kept in the range 90–130 V/m by 
means of the NBS system (corresponding to 56–75 % of the maximal stimulator output). Previous 
works have shown that this stimulation intensity elicits EEG responses with good signal-to-noise 
ratio (Casali et al., 2010; Komssi et al., 2007; Rosanova et al., 2009). The location of the maximum 
EF induced by TMS on the cortical surface was labeled TMS hotspot and was always located 
within the target area. Inter-stimulus interval was randomly jittered between 1500 and 1800 ms 
(equivalent to ca. 0.56–0.67 Hz). This stimulation rate does not induce significant 
reorganization/plasticity processes that might possibly either affect EEG responses to TMS or 
interfere with the longitudinal measurements (Casarotto et al., 2010). During TMS stimulation, 
patients wore inserted earplugs continuously playing a masking noise that abolished the auditory 
potentials elicited by TMS-associated clicks (Massimini et al., 2005a). 
A 60-channel TMS-compatible EEG amplifier (Nexstim Ltd., Helsinki, Finland) was used to record 
artifact-free electrical brain responses to single TMS pulses (Virtanen et al., 1999). On average, 
247 ± 11 (mean ± standard error) pulses were delivered in each session (range 199–332 pulses). 
Impedance at all electrodes was kept below 5 kΩ. EEG signals were band-pass filtered between 
0.1 and 500 Hz and sampled at 1,450 Hz with 16 bit resolution. In order to monitor ocular 
movements and blinks, vertical electrooculogram was recorded with two extra sensors. The 
position of EEG electrodes on the scalp was digitized and provided to the NBS system for 
integration with individual MR images and for allowing a precise replacement of the EEG cap 
between sessions. 
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Data Analysis 
Data analysis was carried out using MATLAB® (2006a, The MathWorks, Natick, MA, USA). 
Principal Component Analysis was applied to automatically reduce ocular artifacts (Casarotto et 
al., 2004). Single TEPs residually contaminated by muscular activity (absolute power of EEG 
channel F8 above 25 Hz > 0.9 μV2/Hz)(van de Velde et al., 1998) were automatically rejected. 
After averaging a minimum of 90 artifact-free trials (mean ± standard error across sessions: 127 ± 
10 trials; range 90–189 trials), channels containing high-frequency muscular activity or large 
residual artifacts were excluded from further analysis. Bad channels (always fewer than ten) were 
usually contaminated by high-frequency muscular activity and were mostly located peripherally 
over fronto-temporal muscles. Signal quality of channels nearby the stimulated site was always 
acceptable. In order to apply data analysis to the same number of channels across sessions and 
patients, we have interpolated bad channels using “Matlab 4 griddata method” (Sandwell, 1987). 
Artifact-free signals were band-pass filtered between 2 and 80 Hz, down-sampled to 725 Hz, and 
re-referenced to the common average reference. 
We measured cortical excitability from the immediate EEG response to TMS. In all patients, TMS 
triggered a large, early TEP component, consisting in a positive wave (Figure 2.2.1a, white 
reversed U-shaped trace) followed by a negative wave (Figure 2.2.1a, white U-shaped trace) and 
with maximum amplitude in the electrode overlying the TMS target. We selected for each patient 
the six neighboring EEG channels (region-of-interest (ROI)) where this component had the largest 
amplitude (Figure 2.2.1a, black traces) and we quantified two morphological features of this 
component, the immediate response area (IRA) and slope (IRS). IRA was obtained from the local 
mean field power (LMFP) of the TEPs across the ROI channels (computed as the square root of 
squared TEPs averaged across the ROI channels; Figure 2.2.1b) (Lehmann and Skrandies, 1980): 
in particular, we detected the two local minima encompassing the early consecutive positive and 
negative evoked waves (light gray shadow, Figure 2.2.1), and then we calculated the integral of the 
LMFP within this interval (dark gray shadow, Figure 2.2.1b). Since TEPs were highly reproducible 
across sessions, we used the same time interval in both pre- and post-ECT sessions. IRS was 
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computed on single-trial TEPs averaged in space across the ROI channels: specifically, it was 
defined as the mean first derivative of the rising side of the positive wave (Vyazovskiy et al., 2008) 
of the early TMS-evoked component (Figure 2.2.1c). Identification of the ROI channels, of the early 
TMS-evoked component, and of the local minima of the LMFP was performed for each patient 
separately with a computerized procedure and was then verified manually. 
In order to study the effects of ECT at the group level, we applied a non-parametric paired sign test 
to compare the HDRS score, IRA, and IRS values between pre- and post-ECT sessions across 
patients. In addition, IRA and IRS values were statistically compared between sessions at the 
single-subject level. In the case of IRA, we applied the following non-parametric permutation-based 
statistical analysis: (i) under the null hypothesis of equivalence between pre- and post-ECT 
recordings, 1000 “mixed” TEPs were constructed by averaging single trials randomly selected from 
the two sessions; (ii) LMFP was computed from these surrogate TEPs and was used to estimate 
the empirical null distribution of IRA; (iii) cortical excitability in each patient was considered 
significantly affected by ECT with probability of false positives α when the actual IRA values laid 
beyond the α-th percentile tails of the null distribution. IRS was compared between sessions by 
non-parametric Wilcoxon rank sum test applied to single-trial slope values in each patient. 
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Figure.2.2.1 - Computation of cortical excitability in patient 1. a Lateral plots represent the average TEPs 
superimposed in all EEG channels before (pre-) and after (post-) ECT. Central map depicts the electrodes 
arrangement (black and gray dots) on the scalp. Black traces correspond to ROI channels, located nearby the 
stimulated site (black cross) and containing a large, early TEP component, consisting in a positive wave (white 
reversed U-shaped trace) followed by a negative wave (white U-shaped trace). b LMFP of the ROI channels. 
Cortical excitability was measured by the subtended area (dark gray shadow) between the two local minima 
(light gray shadow) encompassing the early consecutive positive and negative waves triggered by TMS (IRA). c 
TEPs averaged across the ROI channels in the two conditions. Slanting lines highlight the slope of the rising 
 
2.2.1.2 Results 
At the group level, the clinical effect of ECT was a significant reduction of the HDRS score (p < 
.025) as compared to baseline values (Table 2.2, Figure 2.2.2a left panel). TEPs displayed similar 
morphology across patients and were characterized by an early evoked component consisting of a 
positive wave between 13 ± 2 and 27 ± 5 ms followed by a negative wave peaking at about 47 ± 5 
ms; the grand average TEP across patients (Figure 2.2.2a right panel) shows that the amplitude of 
this component was clearly increased after ECT. IRA and IRS values were significantly increased 
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at the group level after ECT (Table 2.2). Moreover, the increase of IRA after ECT as compared to 
baseline was significantly correlated with the corresponding increase of IRS (Pearson’s correlation 
= .86, R2 = .70, p < .006). 
Statistical analysis further confirmed that the modulation of cortical excitability brought about by 
ECT was significant at the single-subject level. Figure 2.2.2b displays the time course of individual 
TEPs and LMFP within the ROI channels. The morphology of the immediate EEG response to 
TMS was generally comparable among individuals and was highly reproducible between pre- and 
post-ECT sessions in the same patient. Most important, in all patients we observed an increase of 
the consecutive positive and negative waves early evoked by TMS and a corresponding increase 
of the LMFP after ECT. Non-parametric statistical comparison between pre- and post-ECT 
sessions showed that IRA was significantly increased in each and every patient (Table 2.2; Figure 
2.2.2c), while IRS increase was significant in all but 3 patients (Table 2.2; Figure 2.2.2d; patients 3, 
6, 8). 
At the group level, the percentage reduction of HDRS by treatment was inversely correlated with 
the number of ECT sessions (Pearson’s correlation = −.89, R2 = .75, p < .004), indicating that 
mood improved more in patients with a faster response to ECT. A positive trend was observed 
between the percentage reduction of HDRS in post-ECT compared to pre-ECT session and the 
corresponding percentage increase of IRA, although correlation was not statistically significant 
(Pearson’s correlation = .53, R2 = .28, p < .18). 
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Figure 2.2.2 - a (Left) At the group level, the HDRS assessed after (gray bar) ECT was significantly smaller (p < 
.025) than before treatment (black bar). (Right) Superimposition of grand average TEPs collected before (black 
trace) and after (gray trace) ECT. b Individual time courses of the TEPs averaged across ROI channels and of the 
LMFP of ROI channels before (black traces) and after (gray traces) ECT. c Single-subject comparisons (using 
permutation-based statistics) between cortical excitability, as measured by the IRA, before (black bars) and after 
(gray bars) ECT. d Single-subject comparisons (Wilcoxon rank sum test) between the IRS before (black bars) 
and after (gray bars) ECT. *p < .05; **p < .005 
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2.2.1.3 Discussion 
This study provides the first experimental evidence that ECT increases frontal cortex excitability in 
patients affected by severe major depression. This result was obtained by measuring the 
immediate (early and local) EEG response to a direct perturbation with navigated TMS. 
Previous attempts to measure cortical excitability during a course of ECT were performed on the 
peripheral motor evoked potentials (electromyogram (EMG)) induced by TMS of the primary motor 
cortex (Bajbouj et al., 2006, 2005; Chistyakov et al., 2005; Sommer et al., 2002). While single-case 
studies (Bajbouj et al., 2005; Sommer et al., 2002) showed a reduction of cortical excitability after 
ECT (increase of intracortical inhibition, cortical silent period duration, and resting motor threshold), 
group results (Chistyakov et al., 2005) indicated an increase of cortical excitability as reflected by 
reduced motor threshold and intracortical inhibition. In the present study, we stimulated the frontal 
cortex, which is mostly involved by ECT effects (Boylan et al., 2001; Lee et al., 2012), and we 
analyzed the local EEG responses immediately triggered in this area by TMS. Notably, the 
TMS/EEG approach proposed here provides a direct measure of cortical excitability that is 
complementary to the TMS/EMG approach, because it by-passes spinal motorneurons and 
because it is applicable outside the motor cortex. 
Developing TMS/EEG as a clinical tool for monitoring plastic/excitability changes in cortical circuits 
requires an adequate protocol for recording and analyzing data. The TMS/EEG apparatus used in 
this work was equipped with a neuronavigation system and took into account individual anatomical 
variability (Ruohonen and Karhu, 2010). Previous works have shown that TMS-evoked responses 
recorded several days/weeks apart under the same experimental conditions are statistically 
identical (Casali et al., 2010; Lioumis et al., 2009): therefore, the significant TEP changes we 
observed in the same patient between pre- and post-ECT sessions cannot be ascribable to 
unknown experimental variables or measurement uncertainty, but are actually due to significant 
changes in neural responsiveness. The reliability of TEPs is strictly contingent on the use of 
neuronavigation, which ensures a reproducible targeting across sessions. Hence, MR-guided 
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navigated stimulation may be an important requirement for the application of TMS/EEG as a 
clinical monitoring tool. 
We found that the early response of frontal cortical neurons to a direct stimulation was significantly 
larger after a course of ECT treatment as compared to baseline. This result was observed in a 
rather limited population of patients; however, the effect was strong and consistent, since IRA 
increase was statistically significant in each and every patient. Whether this increase in cortical 
excitability reflects synaptic potentiation as suggested by animal models of ECT (Altar et al., 2004; 
Nibuya et al., 1995; Stewart et al., 1994) remains an open question. Indeed, the complex 
relationship between depression and neuroplasticity clearly involves multiple signaling cascades 
that regulate neuronal activity, including inhibitory neurotransmitters (Sackeim, 2004), besides the 
glutamatergic system (Biedermann et al., 2012; Sanacora et al., 2008). Nonetheless, the possible 
involvement of neuroplasticity processes might be supported by the observation that also the slope 
of early TEPs was increased. Indeed, in the animal model, changes in slope of the first local field 
potential component elicited by electrical stimulation of cortical axons reflect changes in excitability 
related to the strengthening or weakening of cortical synapses. Accordingly, in vivo long-term 
potentiation-inducing procedures increase the local field potential slope (Bliss and Lømo, 1973; 
Stewart et al., 1994), whereas long-term depression-inducing procedures reduce it (Kirkwood et 
al., 1993). Actually, IRS increase was significant in most, but not all, of the patients: however, it is 
challenging to properly record the local and immediate neuronal response to TMS, due to 
unwanted activation of cranial muscles nearby the stimulated site. Therefore, although we 
succeeded in recording good-quality early TEPs from most patients, IRA might be an alternative, 
more reliable measure of cortical excitability with respect to IRS in a clinical context. Nonetheless, 
finding a significant increase of IRS at the single-subject level in most patients further supports the 
possible interpretation of increased cortical excitability in terms of neuroplasticity processes. 
Previous studies have related the neurobiological substrates of depression to an inter-hemispheric 
imbalance (Davidson and Irwin, 1999; Hecht, 2010; Maeda et al., 2000): indeed, emotions seem to 
be differently processed in the left and right hemisphere (Grimm et al., 2006) and cerebral blood 
flow and metabolism at rest have been observed to be abnormally reduced in the left prefrontal 
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cortex and abnormally increased in the right prefrontal cortex in major depressed patients as 
compared to healthy subjects (Mayberg, 2003). Moreover, therapeutic repetitive TMS is clinically 
delivered at a high-frequency rate over the left hemisphere (to increase cortical activity) and at a 
low-frequency rate over the right hemisphere (to suppress cortical activity) (Fitzgerald et al., 2003; 
Gershon et al., 2003). As a consequence, it is possible that the mechanism of action of any 
antidepressant treatment could be in principle affected by this asymmetry. The present study was 
not intended to specifically investigate the electrophysiological effects of ECT in the left and right 
hemisphere separately: rather, TMS pulses were delivered on the scalp nearby the mid-sagittal 
plane, slightly on the left side of the head in half of the patients and slightly on the right side in the 
other half. Basically, we stimulated mainly one hemisphere in a region close to the midline and we 
involved, to a lesser extent, also the contralateral hemisphere. The possibility that we actually 
obtained a direct stimulation of both hemispheres is supported by observing that the induced EF 
peaking at 90–130 V/m in the TMS target area actually activated above threshold a cortical area of 
several cm2, as estimated by the navigation system, and that the ROI channels with the largest 
early TMS-evoked EEG response were usually located bilaterally. In two patients we were able to 
record EEG responses to stimulation of both hemispheres: results revealed a significant increase 
of both IRA and IRS in each patient bilaterally. These observations confirm that ECT induces a 
comparable increase of cortical excitability on both sides of the brain, as could be expected by the 
bilateral electrode placement used in this therapeutic protocol. Clearly, most of the patients were 
prevalently stimulated on one hemisphere and therefore we could have missed the observation of 
a possible cortical excitability imbalance at baseline. This issue should be considered in future 
studies on larger sample size by comparing the immediate EEG response to TMS of the left and 
right hemisphere in the same patients. 
The present results, showing increased frontal cortical excitability after ECT, fit with the 
observation that while stress reduces the expression of BDNF in the hippocampus and frontal 
cortex, antidepressants produce the opposite effect and promote neurons/glia survival and growth 
(Duman and Voleti, 2012; Dwivedi Y et al., 2003; Manji et al., 2001; Salvadore et al., 2011). 
Accordingly, ECT increases neurotrophins, e.g. BDNF (Altar et al., 2004; Nibuya et al., 1995) and 
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synaptic efficacy (Stewart et al., 1994), and BDNF/TrkB potentiate cortical excitability through 
interaction with glutamate and its receptors (Mamounas et al., 1995; Mattson, 2008; Minichiello, 
2009). In humans, the glutamate/glutamine levels as measured by proton MR spectroscopy have 
been reported to be significantly smaller at baseline in depressed patients as compared to healthy 
subjects and to increase after successful ECT (Michael et al., 2003). 
We observed a positive, yet not significant, trend between IRA increase and mood improvement as 
measured by HDRS. Although we do not aim to convey any prognostic information due to our 
limited sample size, we propose to further investigate the relationship between clinical and 
electrophysiological measurements of neuromodulatory treatments on larger populations, possibly 
accounting for confounding factors, e.g. gender, disease severity, or social influences. 
A limitation of the present study consists in the lack of a control group, i.e. a comparable group of 
depressed patients treated with “sham” ECT, due to ethical reasons and to the limited number of 
available patients. Previous studies have necessarily applied a classical randomized placebo-
controlled design to demonstrate the therapeutic efficacy of ECT (Freeman et al., 1978; West, 
1981). However, we took for granted the general antidepressant effects of ECT and we specifically 
focused on the electrophysiological modifications induced by this neuromodulatory treatment in 
frontal cortical circuits. Therefore, for our purposes it was unethical to preclude severely depressed 
patients at high risk from receiving a generally effective treatment and, at the same time, to submit 
them to a dose of anesthetic. Since we observed a significant increase of cortical excitability after 
ECT in each and every patient, despite the reduced sample size, we believe it is very unlikely that 
an unknown and uncontrollable variable other than ECT would have been able to significantly 
modulate TEPs consistently across patients. This study showed a clear-cut neurophysiological 
effect of ECT on cortical excitability, that could be detected statistically at the single-subject level: 
therefore, it suggests that a new tool based on TMS/EEG could be available to guide and monitor 
different antidepressant treatments. Clearly, ECT engenders a coarse effect on brain circuits. 
Thus, it would be interesting to employ TMS/EEG study the effects of more refined 
neuromodulatory treatments, e.g. repetitive TMS (O’Reardon et al., 2007; Padberg and George, 
2009; Slotema et al., 2010). rTMS is a non-convulsive mean to induce neuromodulation that does 
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not require anesthesia, and has negligible side effects compared to ECT. In addition, the local 
activation of prefrontal cortical circuits by rTMS has been shown to indirectly affect subcortical 
regions involved in mood regulation (Li et al., 2004). Still, the antidepressant effects of rTMS are 
weaker as compared to ECT (Knapp et al., 2008) and can be unpredictable at the single-patient 
level (Eranti et al., 2007; Hasey, 2001), possibly because of inadequate optimization of stimulation 
parameters, e.g. frequency, intensity, targeting (Hasey, 2001; Lam et al., 2008). To the extent that 
an increase of frontal cortex excitability is the desired electrophysiological effect of antidepressant 
treatment, TMS/EEG measures may represent a reliable tool to quantify objectively and optimize 
therapeutic neuromodulation and may be used to identify effective stimulation parameters on an 
individual basis. For example, IRA can be calculated automatically from a small subset of 
electrodes nearby the TMS target and is able to detect significant effects at the single-subject level. 
Therefore, simpler experimental set-ups could be developed to study the effects of different 
treatments in larger cohorts of depressed patients. In future studies TMS/EEG set-ups may be 
used to evaluate the effects of other treatments, such as sleep deprivation, rTMS, and transcranial 
direct current stimulation. 
2.2.2 Changes of cortical excitability as markers of antidepressant response in 
bipolar depression: preliminary data obtained by combining transcranial magnetic 
stimulation and electroencephalography  
Despite the specific effects of some antidepressants, there is still a high level of uncertainty about 
which biological changes are needed to recover from a major depressive episode (Millan, 2006). In 
the last decade, new approaches have focused on intracellular signalling pathways involved in the 
regulation of synaptic plasticity, cellular survival, and growth (Chen et al., 2010). Neuroimaging and 
postmortem studies revealed cellular and morphological changes in depression, associated with 
reduced grey matter volumes and abnormal decreases in neuron size and glial density (Drevets, 
2000; Manji et al., 2001). These changes remain key targets of antidepressant treatments which 
may reverse depressive symptoms by restoring neuronal growth and activity (Palazidou, 2012). 
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A recent hypothesis, the synaptic homeostatic hypothesis, suggests that learning and plasticity 
processes during wakefulness lead to a net increase of synaptic strength in several cortical 
circuits, and that, after falling asleep, the synaptic potentiation is followed by a homogeneous 
reduction in the strength of all cortical synapses (Huber et al., 2013; Tononi and Cirelli, 2006). In 
vitro and in vivo studies demonstrated a net prevalence of synaptic potentiation processes during 
wakefulness, which results in a gradual build-up of cortical excitability (Bushey et al., 2011; Liu et 
al., 2010; Vyazovskiy et al., 2009, 2008; Yan et al., 2011). In animal models, the increase of the 
slope of the electrical evoked local field potential (LFP), which is a classic marker of synaptic 
strength in vivo, was paralleled by an increase in the level of the glutamate receptor 1 (GluR1)-
containing α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor in 
synaptoneurosomes, and by changes in phosphorylation of AMPA receptors and of the enzymes 
Ca2+/calmodulin-dependent protein kinase II (CamKII) and glycogen synthase kinase 3 beta 
(GSK3B) after prolonged wakefulness (Vyazovskiy et al., 2008). 
The observed correlation between cortical evoked potentials, synaptic strength, and neurobiology 
observed with direct intra-cortical stimulation in rodents (Vyazovskiy et al., 2008) prompted direct 
and non-invasive investigations in humans of the homeostatic changes of cortical excitability by 
means of combined transcranial magnetic stimulation (TMS) and electroencephalography (EEG) 
(Canali, 2014; Ilmoniemi et al., 1997; Komssi and Kähkönen, 2006). Recent studies in humans 
confirmed that the slope and amplitude of the early EEG response to TMS steadily increased 
during prolonged wakefulness, thus paralleling homeostatic sleep pressure (Hanlon et al., 2011), 
and decreased after sleep (Huber et al., 2013). These changes may be used to assess the 
responsiveness of cortical neurons in a way that is more similar to the method classically employed 
in animals, where the slope and amplitude of early LFP induced by electrical cortical stimulation 
are correlates of synaptic building (Bliss and Lømo, 1973; Vyazovskiy et al., 2008). 
Chronobiological research in psychiatry hypothesized that the disruption of the homeostatic 
mechanism of synaptic building could be a key biological correlate and a therapeutic target of 
depressive illness and bipolar disorder (Bhattacharjee, 2007; Wirz-Justice et al., 2004). In 
agreement with this hypothesis, we observed an increase of TMS/EEG measures of cortical 
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excitability after successful antidepressant response to electroconvulsive therapy in a pilot trial in 
nine depressed patients (Casarotto et al., 2013). 
The circadian homeostatic mechanisms are directly targeted by chronotherapeutics, which 
combines interventions in the sleep–wake cycle, such as sleep deprivation, and interventions in the 
molecular machinery of the circadian pacemaker, such as light therapy (Wirz-Justice et al., 2005). 
Sleep deprivation can acutely reverse depressive symptoms in approximately 60% of patients 
(Benedetti and Colombo, 2011), including the most severely affected patients with bipolar 
depression (Benedetti et al., 2014), by acting on many neurotransmitters (Benedetti et al., 2010, 
2007a, 2003; Hefti et al., 2013), and multiple neurobiological factors implicated in plasticity 
processes (Benedetti and Smeraldi, 2009). Sleep deprivation has long been proposed as a model 
experimental treatment to study the neurobiological correlates of rapid antidepressant response 
(Gillin et al., 2001; Schloesser et al., 2012), and recent advances confirmed its pivotal role in 
studying biomarkers of antidepressant response (Benedetti and Terman, 2013; Zarate et al., 
2013). Due to high response rate and rapidity of action, in the last decade clinical 
chronotherapeutics of mood disorders has been developed into a practicable everyday method for 
the treatment of bipolar depression (Benedetti et al., 2014; Wirz-Justice et al., 2013, 2005). 
If an increased cortical excitability, with enhanced synaptic building and activity, is a necessary 
correlate of antidepressant response, and if sleep deprivation promotes neuroplasticity, it can be 
hypothesized that changes in cortical excitability would parallel clinical changes in patients treated 
with antidepressant sleep deprivation. In the present study, we tested this hypothesis by using a 
TMS/EEG technique in a homogeneous sample of depressed patients with bipolar disorder treated 
with chronotherapeutics (combined sleep deprivation and light therapy). 
2.2.2.1 Materials and methods 
Patients 
We included in the study 21 consecutively admitted inpatients (female = 16; male = five) affected 
by a major depressive episode, without psychotic features, in the course of bipolar disorder type I 
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(Structured Clinical Interview for DSM-IV disorders). Inclusion criteria were (i) a baseline Hamilton 
Depression Rating Scale (HDRS) score ≥18; (ii) absence of other diagnoses on Axis I and of 
mental retardation on Axis II; (iii) absence of pregnancy, history of epilepsy, or major medical and 
neurologic disorders; (iv) no treatment with long-acting neuroleptic drugs in the last three months 
before admission; and (v) absence of a history of drug or alcohol dependence or abuse within the 
last six months. 
After a complete description of the study had been provided to the patients, written informed 
consent was obtained. The local ethical committee approved the experimental protocol. 
Treatment and data collection 
All patients were treated for one week with a combined repeated total sleep deprivation and light 
therapy chronotherapeutic treatment (Benedetti et al., 2005). According to established protocols 
(Benedetti, 2012; Wirz-Justice et al., 2013, 2005), each patient was totally sleep deprived on Days 
1, 3, and 5 and each sleep deprivation night lasted for about 36 hours, from 7:00 a.m. to 7:00 p.m. 
of the subsequent day. Under the constant supervision of a nurse, sleep deprivation was carried 
out in a room with 80-lux ambient light. On Days 2, 4, and 6, all patients were allowed to recover 
their sleep (Benedetti et al., 1996). All patients were administered 10,000-lux white light for 30 min, 
given at 3:00 a.m. during the sleep deprivation night and in the morning after recovery sleep, half 
an hour after awakening. Patients were either taking lithium at admission and continued treatment 
(n = 6), or started taking lithium together with the chronotherapeutic procedure to enhance its effect 
and prevent relapse (n = 15) (Baxter, 1985; Benedetti et al., 2014, 1999). 
Electrophysiological measures were recorded during the sleep deprivation treatment. TMS/EEG 
sessions were performed at baseline evening (Day −1: 6:30 p.m.), in the morning and in the 
evening before and after the first night of sleep deprivation (Day 0 and Day 1: 8:30 a.m. and 6:30 
p.m.), in the morning after the first recovery night (Day 2: 8:30 a.m.), and in the morning after the 
third and last sleep deprivation (Day 5: 8:30 a.m.) (Figure 2.2.3). Spontaneous EEG was 
continuously recorded for about three min before each TMS/EEG session. 
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Severity of depression was rated in the mornings of Days 0, 1, 2, and 6 with a modified 21-item 
HDRS from which items that could not be meaningfully rated due to the sleep deprivation 
procedure and to the time frame were excluded (i.e., weight changes and insomnia: items #4, 5, 6, 
and 16) (HDRS-Now) (Leibenluft et al., 1993). A decrease of 50% in HDRS scores after treatment 
was considered the response criterion. 
EEG recording and TMS/EEG targeting 
The experimental set-up included TMS with a focal bipulse 8-coil (Eximia TMS Stimulator; Nexstim 
Ltd, Helsinki, Finland) equipped with a Navigated Brain Stimulation (NBS) system (Nexstim Ltd) 
and a 3D infrared Tracking Position Sensor Unit (Polaris, Northem Digital Inc., Waterloo, Canada). 
EEG was recorded with a 60-channel TMS-compatible EEG amplifier (Nexstim) equipped with 
sample-and-hold circuits that prevents the recording from the powerful TMS-related artefact 
(Virtanen et al., 1999). This equipment provides in real time the TMS coil position and subject's 
head, within the reference space of individual magnetic resonance imaging (MRI), by co-
registration between the fiducial points (nasion, left tragus, and right tragus), selected on the 
individual MRI, and the corresponding digitized scalp landmarks. The exact location of the 
stimulation site was previously adjusted on the individual MRI in order to prevent accidental muscle 
twitches that often affect EEG recordings, and to estimate the electrical field induced by TMS 
pulses, which clearly depends on the stimulation intensity (expressed in V/m). The TMS intensity 
can thus be adjusted according to the maximum electric field intensity (expressed in V/m) 
estimated on the cortical surface, rather than relying on individual motor threshold or on the 
percentage of maximum stimulator output. While bypassing sensory and motor pathways, this 
method allows measurement of cortical excitability and connectivity by directly stimulating any 
given cortical region and simultaneously recording the immediate electrical response (Esser et al., 
2006; Kähkönen et al., 2001). 
Patients were randomly divided into two groups depending on the TMS target location, which was 
slightly adjusted across subjects either to the left (n = 11) or to the right (n = 10) Brodmann area 
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(BA) 6. These prefrontal brain areas showed the greatest changes of metabolic rate and its EEG 
correlates between wake and sleep (Horne, 1993). 
EEG data analysis 
Data analysis was carried out using Matlab (2007b; The Mathworks Inc., Natick, MA, USA). Each 
TMS-evoked response was obtained by averaging 100–200 (mean ± standard deviation across 
sessions: 152 ± 44 pulses) artefact-free trials (Casali et al., 2010; Casarotto et al., 2010). In order 
to quantify the EEG response, we obtained three different cortical excitability measures (Figure 
2.2.3): (i) slope of the first evoked component, defined as the first positive deflection; (ii) local mean 
field power (LMFP), which measures the local amount of electrical activity induced by TMS; and 
(iii) global mean field power (GMFP), which quantifies the overall impact of TMS at all 60 
electrodes. 
In order to reduce point-by-point variability and the number of time-points to allow statistical 
analyses with repeated ANOVAs, we aligned the first EEG component across all patients. We then 
analysed the pattern of changes of cortical potentials, sampled every 2.5 ms, during the first 70 ms 
(where TEP components occurred for all patients), beginning 10 ms after the TMS pulse, due to 
the presence of early and small artefacts. The procedure yielded 21 consecutive time-points for 
each patient. 
The spontaneous EEG was then analysed in order to quantify the spectral power in the theta 
frequency band (4–7 Hz). 
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Figure 2.2.3. - Top panel: Schedule of treatment and data collection, and number of patients participating in each 
transcranial magnetic stimulation (TMS)–electroencephalography (EEG) session. LT = light therapy; S = sleep; 
TMS–EEG = experimental session; W = wake. Bottom panels: (A) Average EEG response to TMS in a subset of 
six selected channels (grey traces). Slope of the first component was computed on TMS-evoked potentials from 
single trials averaged in space across the selected subset of six electrodes (black traces). (B) The electrical 
response under the site of stimulation was quantified by the local mean field power (LMFP) (black trace) and the 
strength of the first two EEG components was calculated as the integral of the LMFP (grey area). (C) Global 
mean field power (GMFP) was measured as the overall impact of TMS at all 60 electrodes. (D) TMS targeting over 
the prefrontal area by means of a neuro-navigation system that ensure stimulation reproducibility across 
sessions. 
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Statistical analyses 
We analyzed the pattern of change over time of the estimated measures of cortical excitability and 
synaptic weights as a function of response to treatment. Of the 21 participants, 12 completed all 
recording sessions and nine missed a mean of mean ± standard deviation (SD) 3 ± 1 sessions. 
Therefore, we followed two separate analytic approaches in the two groups. 
In the subgroup with a complete dataset, a conservative repeated-measures analysis of variance 
was performed in the context of the general linear model. Two repeated measures factors were 
considered in order to investigate (i) circadian changes, morning to evening, during days 0 and 1; 
and (ii) days on treatment. Staying awake at night (sleep deprivation) or asleep (recovery) were 
also modeled as factors. The statistical significance of the effect of the single independent factors 
on the dependent variable at each level was then calculated (least square method) by using 
parametric estimates of the predictor variable. Analyses were performed using commercial 
available software and following standard computational procedures. This analysis was performed 
on the slope of the first evoked component, which was the main outcome measure. With a similar 
approach, we analyzed the patterns of change of GMFP and LMFP values after the TMS pulses, 
using time after stimulus and recording sessions as within-subject factors, and response to 
treatment as a between-subject factor. We also modeled clinical and demographic characteristics 
(age, age at onset, and number of previous episodes) as nuisance covariates. 
In the whole group and using all the available data, we assessed the effects of response to 
treatment on cortical excitability over time using a random regression model (RRM) (Hedeker and 
Gibbons, 1996). The random-effects approach accounts for correlations among repeated 
measurements on the same subjects and has the unique advantage of being unaffected by 
unequal numbers of assessment among individuals, allowing us to use all available data for each 
patient (Gibbons et al., 1993). In the RRM, we included slope values as the dependent variables, 
time (seven recording sessions) and intercept as random effects, and response to treatment plus 
its interaction with time as fixed effects (Gibbons et al., 1993). 
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2.2.2.2 Results 
Clinical and demographic characteristics of the sample divided according to the response to 
treatment are shown in Table 2.3. Confirming previous results (Benedetti et al., 2005), 60% of the 
patients responded to the treatment and did not significantly differ from non-responders on any 
baseline variable. Patients on ongoing lithium treatment and newly started on lithium treatment 
responded equally well. 
 
Table 2.3 - Clinical and demographic characteristics of the patients according to response to 
treatment 
 Responders  
(n = 12) 
Non-responders  
(n = 9) 
R or χ2 p value 
Sex, male/female, n 3/9 2/7 0.14 0.71 
Age, years, mean ± SD 44.08 ± 9.42 41.22 ± 12.02 −0.61 0.54 
Age at onset, years, mean ± SD 27.33 ± 6.63 30.44 ± 11.25 0.79 0.43 
Duration of illness, years, 
mean ± SD 
16.75 ± 8.85 10.77 ± 8.82 −1.53 0.14 
Previous depressive episodes, 
mean ± SD 
7.16 ± 6.14 3.75 ± 2.37 −1.48 0.15 
Previous manic episodes, 
mean ± SD 
2.91 ± 2.19 2.44 ± 2.29 −0.47 0.63 
Duration of current episode, 
weeks, mean ± SD 
33.16 ± 42.33 23.33 ± 19.33 0.64 0.52 
Education, years, mean ± SD 12.36 ± 4.15 14.00 ± 6.00 0.70 0.49 
Ongoing lithium treatment, yes/no, 
n 
4/8 2/7 0.01 0.94 
HDRS score (17 items), 
mean ± SD 
Baseline 19.58 ± 5.66 20.66 ± 4.15 −0.48 0.63 
Day 1 10.91 ± 6.96 15.22 ± 6.07 −1.47 0.15 
Day 2 9.50 ± 5.12 14.66 ± 3.60 −2.57 0.01 
Day 6 4.33 ± 3.42 16.00 ± 5.31 −6.12 0.00 
HDRS = Hamilton Depression Rating Scale; SD = standard deviation. 
aHDRS 50% reduction from Day 1 to Day 5. 
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Synaptic strength (slope of the first-evoked component) 
The pattern of change of the slope of the first component over time was influenced by circadian 
phase (morning versus evening), sleep, and sleep deprivation treatment (Figure 2.2.4). The overall 
change over time during treatment was highly significant because of a sawtooth pattern of increase 
after wake and decrease after sleep, with a significant trend of progressive increase during the 
whole treatment (GLM repeated measures ANOVA, Day −1 to 5: F = 4.35; df = 6,66; p = 0.00092). 
Slope significantly increased during the day, from morning to evening, starting before the first sleep 
deprivation (Day 0: F = 7.90; df = 1,11; p = 0.01691 and continuing to the day after sleep 
deprivation (Day 1: F = 19.02; df = 1,11; p = 0.00113). The size of the circadian change did not 
significantly differ before and after sleep deprivation (F = 0.44; df = 1,11; p = 0.51944). 
Sleep deprivation significantly increased the slope (F = 13.23; df = 1,11; p = 0.00389), while 
recovery sleep decreased it (F = 18.99; df = 1,11; p = 0.00113), with a significant interaction 
between the two effects (F = 41.96; df = 1,11; p = 0.00004). This effect of sleep was not observed 
at baseline (F = 3.13; df = 1,11; p = 0.10), thus leading to significant differences in the effects of 
sleep before and after the first sleep deprivation: baseline sleep did not influenced the slope, while 
recovery sleep after sleep deprivation decreased it (F = 4.90; df = 1,11; p = 0.04875). 
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Figure 2.2.4. - (A) Topographical maps of scalp voltages in a representative subject of the responder group 
throughout the experimental week. (B) Pattern of change of slope values (μV/ms) over time (M = morning, E = 
evening) in the whole sample. Points = means; whiskers = standard errors. (C) Percent variation of slope values 
from baseline for each participant. 
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Effect of treatment 
The patterns of mood change during treatment markedly differed between responders and non-
responders (Figure 2.2.5A). RRM analyses in the whole dataset confirmed the significance of the 
progressive increase of slope values over time (p = 0.00565) and showed a significant effect of 
response (p = 0.043); i.e., patients who responded to treatment had higher slope values than non-
responders throughout the study period (Figure 2.2.5B). 
 
 
Figure 2.2.5. - Changes of Hamilton Depression Rating Scale (HDRS) scores of depression severity (A) and of 
the slope of the first-evoked component (μV/ms) (B) during treatment in the sample divided according to final 
response to treatment (HDRS 50% reduction). 
 
Cortical excitability: changes of GMFP and LMFP and effects of treatment 
Baseline cortical excitability (GMFP and LMFP) was significantly higher in responders than in non-
responders (LMFP: F = 2.08; df = 20,340; p = 0.00445; GMFP: F = 1.64; df = 20,320; p = 0.04199). 
 
40 
 
These differences were maintained during the day (Day 0: morning and evening), with a similar 
pattern of circadian change from morning to evening among patients but with higher values in 
responders than in non-responders (LMFP: F = 2.49; df = 20,240; p = 0.00057; GMFP: F = 2.10; df 
= 20,240; p = 0.00471). 
Two ANOVAs were conducted separately for the effects of the first sleep deprivation (Day 0–1) 
and of the whole treatment week. The analyses of the pattern of change of the evoked GMFP 
response before/after the first sleep deprivation cycle (Figure 2.2.6) showed that: (i) the evoked 
response over time (msec) was overall higher in responders than in non-responders (time × 
response interaction: F = 2.54; df = 20,180; p = 0.000577); (ii) there was a significant interaction 
effect of circadian timing (morning versus evening) and response to treatment on the pattern of 
GMFP, due to a better enhancement during the day in responders (F = 1.7; df = 20,180; p = 
0.03557); and (iii) after sleep deprivation, responders tended to increase the GMFP response and 
its circadian fluctuations, while non-responders did not (four-way interaction of sleep deprivation 
treatment, response to treatment, and circadian timing on the GMFP pattern of response: F = 1.94; 
df = 20,180; p = 0.01215). 
Similar effects were observed when analysing all sessions (seven TMS/EEG sessions) in the 
subgroup of patients with a complete data recording (n = 12). A two-way repeated ANOVA 
confirmed a significant interaction of time and response (LMFP: time, F = 1.48; df = 6,36; p = 
0.21009; response, F = 6.75; df = 1,6; p = 0.04069; interaction, F = 1.36; df = 120,720; p = 0.0095; 
GMFP: time, F = 0.47; df = 6,36; p = 0.8235; response, F = 5.88; df = 1,6; p = 0.0515; interaction, 
F = 1.24; df = 120,720; p = 0.04938), meaning that the pattern of increasing cortical excitability 
after the sleep deprivation treatment did not follow parallel slopes of time-course in responders and 
in non-responders to treatment. 
Additional analyses were performed using, as a dependent variable, the integral of the LMFP 
within the first two components of the EEG response, and gave similar results. Finally, EEG theta 
power increased after sleep deprivation and decreased after sleep during the experimental period, 
with a significantly lower increase in responders to treatment, in agreement with previous studies 
showing less night sleep after sleep deprivation in responders than in non-responders (Benedetti et 
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al., 2007b). Changes in measures of cortical excitability did not significantly differ between patients 
on ongoing lithium and those newly started on lithium treatment). 
 
 
Figure 2.2.6. - Global mean field power (GMFP) values (μV/ms) before and after the first sleep deprivation cycle. 
Black circles are mornings; white circles are evenings. TSD + LT = total sleep deprivation + light therapy. 
 
2.2.2.3 Discussion 
Our patients showed a sawtooth pattern of increased cortical excitability during wake and 
decreased cortical excitability during sleep. Despite a similar pattern of variation in responders and 
non-responders, measures of synaptic strength were markedly lower at baseline in non-
responders, and after treatment did not even reach the baseline values of responders. This 
fluctuation of cortical excitability around a lower mean value is a new biological correlate of non-
response, independent of comparable baseline severity of depression and clinical characteristics. 
This effect suggests that the baseline status of the brain could be a major factor affecting 
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antidepressant response, and that mechanisms underlying cortical excitability can be involved in 
the biological changes needed to recover from depression. 
In comparison with observations in healthy subjects (Huber et al., 2013), the circadian pattern of 
progressive increase of cortical excitability during wake, which has been proposed as a 
neurophysiological correlate of synaptic homeostasis (Tononi and Cirelli, 2006), was absent at 
baseline in our patients, in agreement with current perspectives on impaired sleep homeostasis in 
patients with bipolar disorder (Harvey, 2008) and in animal models of depression (Savelyev et al., 
2012). Moreover, the relative circadian increase showed a higher individual variability in our 
patients than in healthy subjects (Huber et al., 2013), which needs direct case–control 
comparisons to be clarified. 
Cortical excitability has been proposed as a physiological correlate of process S, and our findings 
then confirm hypotheses of process Sincrease as a core mechanism of action of antidepressant 
sleep deprivation (Vyazovskiy et al., 2008; Wirz-Justice and Van den Hoofdakker, 1999). Given 
that changes of synaptic strength during the sleep–wake cycle suggest that sleep deprivation is 
associated with synaptic potentiation (Bushey et al., 2011; Cirelli, 2009; Liu et al., 2010; Rao et al., 
2007; Tononi and Cirelli, 2006), it is tempting to surmise that the progressive enhancement in 
cortical excitability after sleep deprivation in bipolar depression may capture changes of synaptic 
efficiency and neuroplasticity. 
Definite conclusions on this topic are hampered by a lack of basic data on the neurobiological 
meaning of these neurophysiological measures in humans. In animal models and in vitro, the slope 
of early local field potential, which is induced by electrical intra-cortical stimulation, is a clear-cut 
correlate of synaptic building and homeostatic sleep pressure (Vyazovskiy et al., 2008); and long-
term potentiation (LTP) increased local field potential slope (Bliss and Collingridge, 1993; 
Glazewski et al., 1998; Iriki et al., 1991), while long-term depression (LTD) reduced it (Kirkwood et 
al., 1993). In humans, the delivery of repeated TMS (rTMS) over the motor cortex provided the first 
demonstration of LTP, which was measured as the increased EEG cortical response to TMS using 
our same TMS/EEG method (Esser et al., 2006). This suggests that the combination of TMS and 
EEG provides a means of approximating the classical stimulation protocols available for animal 
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models. This hypothesis is supported by the convergent findings on the circadian cyclicity of 
cortical excitability, observed with direct intra-cortical stimulation and recordings in rodents, and 
with TMS/EEG in humans (Huber et al., 2013; Vyazovskiy et al., 2008). 
Several non-alternative mechanisms can contribute to the effects of chronotherapeutics on 
measures of synaptic homeostasis. Sleep deprivation directly targets the glutamatergic system, by 
reducing N-methyl-D-aspartate (NMDA) sensitivity (Novati et al., 2012) and increasing the 
circadian peaks of glutamate production (Dash et al., 2009), with changes of glutamate/glutamine 
concentrations after sleep deprivation being proportional to mood improvements (Benedetti et al., 
2009). Moreover, sleep deprivation can promote a rapid and robust expression of plasticity related 
factors, including brain-derived neurotrophic factor (BDNF), its receptor tropomyosin related kinase 
B (TrkB) and cyclic adenosine monophosphate response element-binding protein (CREB) (Duman 
et al., 2000), with the increase of BDNF levels positively correlating with antidepressant response 
to sleep deprivation (Gorgulu and Caliyurt, 2009). Sleep deprivation potentiates the serotonin, 
noradrenaline, and dopamine neurotransmitter systems, which can contribute to circadian changes 
of cortical excitability by boosting synaptic plasticity (Connor et al., 2012), regulating neuronal 
excitability and synaptic transmission, integration and plasticity (Tritsch and Sabatini, 2012), and 
maintaining the neocortical activity-dependent excitatory–inhibitory balance(Moreau et al., 2013). 
Finally, sleep deprivation targets the circadian pattern of the secretion of pro-inflammatory 
cytokines (Voderholzer et al., 2012, 2004), which are key mediators of the homeostatic response to 
sleep loss (Krueger et al., 2001; Wisor et al., 2011). 
Whatever the exact mechanism, our observation suggests that TMS/EEG measures of cortical 
excitability could be proposed as novel biomarkers of antidepressant response. In a previous pilot 
study, using this same TMS/EEG method, we observed an increase in the slope after 
electroconvulsive therapy in patients affected by severe major depression resistant to drug 
treatments (Casarotto et al., 2013); remarkably, similar to our present observations, non-
responders showed significantly lower baseline slope values than responders (0.11 ± 0.09 versus 
0.50 ± 0.24, respectively; t = 2.57, p = 0.042), and post-treatment values of non-responders did not 
reach the baseline values of responders. 
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Patients with bipolar disorder spend a substantial proportion of their time ill (Altshuler et al., 2010), 
with depression representing their predominant abnormal mood state (Kupka et al., 2007), despite 
prolonged and highly complex medication regimens to achieve a stable response in bipolar 
disorder (Post et al., 2010). Hence the interest in novel biomarkers which could speed up the 
investigation of new treatments, by providing surrogate indices of clinical endpoints and promoting 
the identification of new targets (Zarate et al., 2013). Albeit technically demanding, the TMS/EEG 
procedure is now established, and can thus be tested in different clinical settings to be validated 
with further research using other antidepressant treatments (Canali, 2014). 
This study, which was correlational in nature, has several limitations, including the rather small 
sample size, and issues of generalizability, patients being non-drug-naïve, the lack of a placebo 
control, and possible population crypto-stratification. Our measures closely resemble those 
obtained with electrophysiological studies in rodents, where, however, the slope of the early LFP 
was measured after having been induced by direct electrical stimulation: the interpretation of the 
different absolute values obtained using a TMS/EEG method in responders and non-responders 
thus requires further basic research in humans. Nevertheless, considering the close link between 
cortical excitability and both synaptic neurobiology and clinical response to treatment, further 
exploration of these biomarkers in depression is warranted. 
2.2.3 Shared reduction of oscillatory natural frequencies in bipolar disorder, major 
depressive disorder and schizophrenia 
High-frequency gamma oscillations are critical for communication among brain areas, thus allowing 
integration among cortical modules (Nikolić et al., 2013; Rodriguez et al., 1999; M. A Whittington et 
al., 2000). In the last decade clinical research on oscillatory brain dynamics reported altered 
neuronal oscillations in neuropsychiatric disorders (Başar, 2013; Başar and Güntekin, 2008; 
Herrmann and Demiralp, 2005; Uhlhaas and Singer, 2010), suggesting that reduced gamma 
oscillations could be common to bipolar disorder (BPD), major depressive disorder (MDD) and 
schizophrenia (SCZ) (Maharajh et al., 2007; B. F O’Donnell et al., 2004). 
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Frontal cortical gamma activity (30–50 HZ), as indexed through electroencephalography (EEG), is 
reduced in patients with SCZ (Uhlhaas et al., 2008), in response to odd-ball paradigm (Gallinat et 
al., 2004; Haig et al., 2000; Symond et al., 2005) or cognitive control task (Cho et al., 2006). EEG 
power and phase synchronization in beta/gamma frequencies bands after to 40 Hz auditory 
stimulation are also reduced (Kwon et al., 1999; Light et al., 2006). Findings in mood disorders are 
similar. BPD patients in the manic or mixed state show hampered auditory EEG synchronization in 
beta/gamma band (20–50 Hz) during a click trains paradigm (B.F. O’Donnell et al., 2004), and 
reported significantly reduced long distance gamma coherence in a visual odd-ball paradigm 
(Özerdem et al., 2011). A recent study reported a decrease of frontal gamma oscillations in 
patients with MDD and BPD in response to implicit emotional tasks (Lee et al., 2010; Liu et al., 
2012). A reduced phase locking and evoked power at 40-Hz auditory steady-state stimulation in 
first episode psychosis of patients with either schizophrenia or affective disorders has also been 
reported (Spencer et al., 2008). 
The combination of transcranial magnetic stimulation with high-density electroencephalographic 
recording (TMS/EEG) represents a provocative approach useful to identify the integrity of 
thalamocortical circuits by directly challenging the brain's capacity to produce and sustain 
oscillatory activity (Buzsáki and Watson, 2012; Canali, 2014; Rosanova et al., 2012). By combining 
TMS/EEG we previously demonstrated that each cortical region perturbed by TMS tend to oscillate 
at specific natural frequency (Rosanova et al., 2009), and we found a deficit in the oscillatory 
properties in schizophrenia resulting in a reduction of frontal natural frequencies (Ferrarelli et al., 
2012, 2008). Here we hypothesized impairments of the thalamocortical system to produce fast 
oscillations in bipolar disorder and major depression. We then aimed at investigating the oscillatory 
properties of the premotor cortex by employing TMS/EEG in two groups of patients with bipolar 
disorder and major depression, and using a group of healthy subjects as negative controls and a 
group of patients with schizophrenia as positive controls. 
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2.2.3.1 Methods 
We studied 12 healthy subjects as controls (HC), and 36 consecutively admitted in patients 
suffering from three different psychiatric disorders (DSM-IV criteria, SCID interview): either major 
depressive episode, without psychotic features, in course of BPD (n=12) or in course of MDD 
(n=12), or chronic undifferentiated schizophrenia (n=12). Inclusion criteria were the absence of 
other diagnoses on axis I and of mental retardation on axis II; absence of pregnancy, history of 
epilepsy, or major medical and neurologic disorders; absence of a history of drug or alcohol 
dependency or abuse within the last 6 months. Six BPD were taking lithium salts. All MDD patients 
were on antidepressanttreatment, also with benzodiazepines (n=8) or mood stabilizers (n=3). SCZ 
patients were taking antipsychotics (typical neuroleptics: n=5; a typical antipsychotics: n=7). A 
written informed consent was obtained for all study participants. The local ethics committee 
approved the experimental protocol. 
The experimental setup included a TMS compatible 60-channel EEG amplifier (Nexstim) equipped 
with sample-and-hold circuits that prevents the recording from the powerful TMS-related artifact 
(Virtanen et al., 1999). Accuracy and reproducibility of TMS/EEG responses were controlled with a 
Navigated Brain Stimulation (NBS) system (Nexstim) and a 3D-infrared Tracking Position Sensor 
Unit (Northem Digital Inc). TMS was delivered on the convexity of the middle caudal portion of the 
superior frontal gyrus close to the midline (Broadmann's areas 6), with the current perpendicular to 
its main axis. To ensure significant EEG responses (Casali et al., 2010; Komssi et al., 2007; 
Rosanova et al., 2009) intensity of TMS induced electric field was always >90 V/m as estimated by 
the NBS system, for each study participant. We delivered about 200–300 stimuli for each session 
at a frequency randomly jittered between 1.5 and 1.8 s (equivalent to about 0.5–0.6 Hz). Data 
analysis was carried out using Matlab with the EEGLAB toolbox (Delorme and Makeig, 2004). 
Each TMS-evoked response was obtained by averaging 150–250 artifact free trials.  
In order to quantify the responses in the time-frequency domain (Delorme and Makeig, 2004), from 
each TMS/EEG session, we measured the event-related spectral perturbation (ERSP) changes in 
the power spectrum using wavelet decomposition (3.5 oscillation cycles) across single-trials at the 
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channel closest to the stimulation site. The ERSP was normalized by subtracting the mean 
baseline power spectrum. Significant ERSP were evaluated by applying a bootstrap statistical 
method based on a surrogate distribution randomly derived from the pre-stimulus onset (ranging 
from −700 to −50 ms). Statistical significance level was set at p<0.01 and only significant values 
were considered in the analysis. Averaged ERSP values across all trials of a session were 
calculated between 8 and 50 Hz (1 Hz bin resolution) over a 20–300 milliseconds time window, 
corresponding to the main EEG activity evoked by TMS. The natural frequency was computed as 
the frequency bin with the largest cumulated ERSP over time (Rosanova et al., 2009). Differences 
between the frontal natural frequencies of the four study groups were analyzed with one-way 
ANOVA followed by post-hoc Newman–Keuls's tests. Pearson correlation analysis between 
medications doses, clinical variables and natural frequency were performed. Analyses were carried 
out using a commercial available software (StatSoft Statistica) and following standard 
computational procedures (Hill and Lewicki, 2006). 
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2.2.3.2 Results 
Clinical and demographic characteristics of the sample divided according to diagnosis, and the 
evoked natural frequencies, are resumed in table 2.4. 
 
Table 2.4 - Demographic and Clinical Characteristics of the study groups 
 
Healthy 
subjects 
Bipolar 
disorder 
Major 
depression 
Schizophrenia F P 
Gender (m/f) 5/7 2/10 4/8 9/3   
Age (yrs) 39 (15) 36 (7) 46 (8) 38 (9) 2.1 0.1 
Age at onset (yrs)  25 (6) 29 (9) 25 (6) 1.1 0.3 
Duration of illness 
(yrs) 
 11 (9) 18 (10) 13 (6) 0.1 0.1 
PANSS (positive)    18 (4)   
PANSS (negative)    18 (4)   
PANSS (general)    37 (5)   
HDRS (baseline)  26 (6) 24 (7)  1.1 0.8 
Frontal natural 
frequency (Hz) 
27.25 (3.22) 20.30 (3.72) 19.24 (5.03) 20.30 (4.22)   
Values are expressed as mean and standard deviations. 
 
All four groups were closely age-matched. Patients with bipolar or unipolar depression had a 
similar age at onset and duration of illness and did not differ on the Hamilton Depression Rating 
Scale (HDRS) score. Patients with schizophrenia reported positive and negative symptoms as 
measured by PANSS.  
Data obtained with the TMS/EEG procedure are resumed in Figure 2.2.7. 
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Figure 2.2.7. - Top panel: (a) average EEG responses to TMS (grey traces represent the 60 recording channels) 
for the channel closest to the stimulation site (black trace) over the premotor area; (b) color-coded: event-
related spectral perturbation (ERSP) plots reflect the significant TMS related changes in amplitude and their 
duration. Dotted lines show the frequency with the highest activity (natural frequency). Data are shown from a 
representative subject from each of the four groups. Bottom panel: individual natural frequencies values for 
healthy control subjects (negative controls) and patients with bipolar disorder, major depressive disorder and 
schizophrenia (positive controls). 
 
TMS significantly activated the beta/gamma band response (range 21–50 Hz) to frontal cortical 
perturbation in HC. The main frequencies of frontal EEG responses to TMS were significantly 
reduced in patients with either BPD, MDD or SCZ (range 11–27 Hz; one-way ANOVA: F=12.31; 
df=3,44; p=0.000006) ( Figure 2.2.7c). Frontal natural frequencies were markedly faster in healthy 
subjects compared to all the patient groups (post-hoc:p=0.000485 vs SCZ, p=0.000171 vs MDD, 
and p=0.000290 vs BP, respectively), which did not significantly differ among themselves. 
Correlational analyses between natural frequencies and HDRS, PANSS scores and medication 
doses did not show significant effects. 
2.2.3.3. Discussion 
This is the first study to provide a TMS/EEG direct measure of frontal natural oscillations in patients 
with either BPD or MDD, compared to HC and SCZ. We extended the finding of reduced gamma 
oscillations, previously reported in SCZ, to mood disorders. All the three diagnostic conditions were 
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associated with significantly slower gamma-band oscillations compared to healthy controls, and did 
not differ among themselves. 
Common to these psychiatric conditions, a biological underpinning of slower gamma-band 
oscillations could be found in abnormal ϒ-aminobutyric acid (GABA) neurotransmission. 
TMS/EEG can assess cortical inhibition due to inhibitory GABA interneurons (Daskalakis et al., 
2002b), and short cortical inhibition, interhemispheric inhibition and cortical silent period are 
decreased in SCZ (Daskalakis et al., 2002a; Fitzgerald and Daskalakis, 2008), MDD (Lefaucheur 
et al., 2008; Levinson et al., 2010) and BPD (Levinson et al., 2007). Gamma oscillations may 
reflect the activity of GABA inhibitory interneurons (Brenner et al., 2009; Gonzalez-Burgos and 
Lewis, 2008; Gray and McCormick, 1996; Traub et al., 2005), which produce and sustain complex 
large-scale network oscillations in fast frequency bands (40–100 Hz) (Benes and Berretta, 2001), 
also generating inhibitory potentials in excitatory pyramidal neurons (Whittington et al., 2011). 
GABAa receptor agonizts activate, and antagonists block, high frequency oscillations (Whittington 
et al., 1995). Fast parvalbumin-expressing GABA interneurons are necessary for high-frequency 
oscillations (Bartos et al., 2007; Uhlhaas et al., 2008), and recent animal studies demonstrated that 
their inhibition resulted in gamma suppression (Sohal et al., 2009). Similarly, decreasing fast-
spiking interneuron activity reduced power and synchronization of gamma oscillations (Spencer, 
2009), while its activation induced gamma power increase (Cardin et al., 2009). 
GABA-ergic neurotransmission has been extensively studied in psychiatry (Başar, 2013). Post-
mortem, low GABA levels were found in SCZ (Volk and Lewis, 2002) and MDD (Rajkowska et al., 
2007), and the GABA-synthesizing enzyme GAD1 and GAD67 were altered in SCZ and BPD 
(Akbarian and Huang, 2006; Gonzalez-Burgos and Lewis, 2008). In depressed suicide victims 
GABAa receptor mRNA expression was reduced in hippocampus, amygdala and frontal cortex 
(Merali et al., 2004; Poulter et al., 2010). Reduced density of gabaergic neurons was found in the 
cortex of patients with either BPD or SCZ (Benes and Berretta, 2001), with reduced GABA 
synthesis in PV-interneurons (Lewis et al., 2005) in SCZ, suggesting a considerable overlap in 
inhibitory interneuron abnormalities in neuropsychiatric disorders. Brain magnetic resonance 
spectroscopy revealed low GABA levels in prefrontal cortex of patients with MDD (Hasler et al., 
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2007; Price et al., 2009) and BPD (Bhagwagar et al., 2007). Altogether, these data support the 
hypothesis that abnormal GABAergic neurotransmission could be critical to explain the abnormal 
ϒ-oscillations observed in our patients (Sohal et al., 2009; M. A. Whittington et al., 2000). 
GABAergic neurotransmission is a therapeutic target in mood disorders and in SCZ. GABA levels 
increase with mood-stabilizing medications such as valproate and lithium in BPD (Malhi et al., 
2013). High-frequency repetitive transcranial magnetic stimulation (rTMS) enhances GABA-
inhibitory mechanisms (Daskalakis et al., 2006), and increases gamma-oscillations in HC (Barr et 
al., 2009). Indeed, rTMS has been shown to improve cognitive deficits in MDD (Downar and 
Daskalakis, 2013) involving synaptic modulation and plasticity (Esser et al., 2006). Deficits in the 
modulations of the dopamine system may trigger the appearance of a defective GABA (Benes and 
Berretta, 2001). Recent studies reported that clozapine treatment may potentiate GABA receptors 
in schizophrenia patients (Liu et al., 2009). 
However, patients with MDD and BPD showed reduced gamma activity even after complete 
remission (Özerdem et al., 2011; Shaw et al., 2013), suggesting that successful treatment is 
unable to normalize these core biological features of the disorders. A recent study reported a 
deficit to produce frontal fast oscillations, independent of medication status (Minzenberg et al., 
2010). Here we did not find any correlation between medication doses and natural frequencies. We 
also previously reported that the natural frequencies of different cortical areas, other than the 
frontal ones, were not altered in medicated SCZ patients, while if medications would affect 
neuronal oscillations one would expect a generalized effect (Ferrarelli et al., 2012). 
Strengths of the present study include a focused research question, state-of-the-art TMS/EEG 
methods, and straightforward effects. However, our experimental setting did not allow to directly 
assess the role of deeper structures, such as hippocampus, which contribute to gamma oscillations 
(Başar et al., 2001). We obtained an excellent power to study group differences, but could not 
consider other biological markers, gene variants, and their interaction with clinical variables. 
Patients were non drug-naïve. Recruitment was in a single ethnic group, thus raising the possibility 
of population stratifications limiting the generalizability of the findings. 
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In conclusion, these limitations do not bias the main finding of significantly lower natural frequency 
of frontal cortico-thalamocortical circuits in patients with BPD, MDD, and SCZ, which suggest their 
possible relevance as an endophenotype common to major psychoses. 
2.3 – Quantifying cortical EEG responses to TMS in (un)consciousness. 
Excitability and effective connectivity are key parameters of cortical circuits’ functioning. Moreover, 
alterations of these parameters have been suggested to underlie neurologic and psychiatric 
conditions. 
Some recent studies employed TMS/EEG to measure cortical excitability and effective connectivity 
in healthy subjects during wakefulness, slow-wave sleep, REM sleep, and benzodiazepine induced 
anesthesia. 
In a first set of experiments (Rosanova et al., 2009) TMS was targeted over three different cortical 
sites (one occipital, one parietal and one frontal region) of six healthy subjects and the ensuing 
EEG oscillations were recorded. Indeed, TMS consistently evoked dominant alpha-band 
oscillations (8–12 Hz) in the occipital cortex, beta-band oscillations (13–20 Hz) in the parietal 
cortex, and fast beta/gamma-band oscillations (21–50 Hz) in the frontal cortex. In a second series 
of experiments, Massimini and colleagues (Massimini et al., 2005a; M. Rosanova et al., 2012) 
recorded TMS-evoked brain responses in healthy subjects whose level of consciousness was 
experimentally manipulated under both physiological (Massimini et al., 2010, 2007, 2005b) and 
pharmacological (Ferrarelli et al., 2010) conditions, and compared the obtained responses to those 
recorded during wakefulness. They then extended these initial observations to the study of 
pathological conditions in which consciousness was impaired and performed TMS/EEG 
measurements in brain-injured patients with a broad spectrum of clinical diagnoses, ranging from 
the vegetative state (VS)/unresponsive wakefulness syndrome (UWS) to the minimally conscious 
state (MCS) and locked-in syndrome (LIS). 
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Most important, they show that the EEG response to TMS, once all confounding factors are 
controlled for, reflects only the intrinsic properties of targeted cortical circuits rather than physical or 
biological artifacts. 
NREM Sleep 
In a first series of studies, Massimini and colleagues investigated the changes in TMS-evoked EEG 
responses during the transition from wakefulness to NREM sleep early in the night, when 
consciousness fades (Massimini et al., 2005b). During wakefulness, TMS triggers a sequence of 
low-amplitude, high-frequency (ranging from 10 to 30 Hz) waves associated with a differentiated (in 
both space and time) pattern of cortical activations (Rosanova et al., 2009) that propagate along 
long-range ipsilateral and transcallosal connections (Figures 2.3.1A and 2.3.1B, left). Thus, in line 
with the theoretical requirements, during conscious wakefulness a direct cortical perturbation 
resulted in complex activity patterns that are, at once, distributed within a system of interacting 
cortical areas (integrated) and differentiated in space and time (information-rich).  
In contrast, during NREM sleep, TMS delivered, with the same stimulation parameters, invariably 
produces a simple wave of activation that remains localized to the site of stimulation, indicating a 
breakdown of communication and a loss of integration within thalamocortical networks (Massimini 
et al., 2005b) (Figure 2.3.1A, middle). In other words, when subjects lose consciousness during 
NREM sleep, TMS triggers a low-frequency wave, associated with a strong initial cortical 
activation, which does not propagate to connected brain regions and dissipates rapidly. 
Interestingly, the disappearance of a complex spatiotemporal pattern of cortical activation is not 
simply due to a reduction of responsiveness of hyperpolarized cortical neurons. In fact, when TMS 
is applied at progressively higher intensity the initial activation is followed by a larger negative 
wave that spreads like an oil spot to vast regions of the cortex. Particularly, when TMS is applied 
over the parietal cortex this wave reaches period-amplitude criteria of a full-fledged sleep slow 
wave (Massimini et al., 2007). Thus, during NREM sleep an increase of the spread of the response 
(integration) comes with the price of a loss of differentiation (Figure 2.3.1A, middle). 
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Overall, these results demonstrated that during NREM the thalamocortical system, despite being 
active and reactive, loses its ability to engage in complex activity patterns (Casarotto et al., 2010; 
Rosanova et al., 2009) that are, at once, distributed within a system of interacting cortical areas 
(integrated) and differentiated in space and time (information-rich); it either breaks down in casually 
independent modules (loss of integration) or bursts in an explosive response (loss of 
differentiation/information). 
 
 
Figure 2.3.1 - Loss and recovery of integration and information in thalamocortical networks. During wakefulness 
(A, left), TMS triggers a sustained response made of recurrent waves of activity associated with spatially and 
temporally differentiated patterns of activation (brain complexity). During NREM sleep (A, middle), anesthesia 
(B), and vegetative state (C, left) the thalamocortical system, despite being active and reactive, loses its ability 
to engage in complex activity patterns and either breaks down in casually independent modules (loss of 
integration) or it bursts in an explosive response (loss of differentiation/information). During REM sleep (A, 
right) and in MCS (C, middle) and LIS patients (C, right), the TMS response shows a recovery of recurrent waves 
of activity associated with spatially and temporally differentiated patterns of activation. 
 
Midazolam Anesthesia 
These observations have been replicated in a recent set of experiments where it has been tested 
whether cortical effective connectivity would show a breakdown, similar to the one observed in 
deep NREM sleep, during LOC induced by a pharmacological agent, midazolam, delivered to 
healthy participants at anesthetic concentrations (Ferrarelli et al., 2010). Similar to NREM while 
during wakefulness TMS triggered complex responses involving multiple cortical areas distant from 
the site of stimulation, during midazolam-induced LOC, TMS evoked a positive–negative response 
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that was initially larger but that remained local (Figure 2.3.1B, right). As during NREM sleep, also 
during midazolam anesthesia, this stereotypical response evolved into a full-fledged slow 
oscillation when the cerebral cortex was stimulated at higher intensity(Massimini et al., 2012). 
Dreaming 
One of the most striking paradoxes sleep can offer is represented by dreaming. A person lying 
down with eyes closed—as during NREM sleep—disconnected from the external environment, 
almost completely paralyzed and unresponsive, is consciously experiencing something that closely 
resembles waking activity, and upon awakening is able to verbally report its content. Dreamlike 
consciousness occurs during various phases of sleep, including sleep onset and late night, 
especially during rapid eye movement (REM) sleep. Thus, to probe the internal dialogue of the 
thalamocortical system even in the absence of any behavioral cue, it has been recorded the TMS-
evoked responses during REM sleep in healthy subjects whose consciousness regained in the 
form of long and vivid dreams (Massimini et al., 2010). Consistent with the theoretical predictions, 
the recovery of conscious experience during REM was accompanied by a widespread and 
differentiated pattern of cortical activation similar to those observed during wakefulness (Figure 
2.3.1A, right). 
Severe Brain Injury 
Finally, it has been investigated whether a stereotypical pattern of cortical responses (similar to 
NREM sleep and midazolam anesthesia) was present also when consciousness was lost due to 
brain insults (Rosanova et al., 2012). To do so, it has been employed TMS/EEG to measure 
cortical responses at the bedside of VS/UWS patients (ie, awake, but entirely unaware). To 
minimize the possibility of a misdiagnosis due to fluctuations in behavioral responsiveness, clinical 
assessment was performed by means of the Coma Recovery Scale–Revised (CRS-R)(Giacino et 
al., 2004) repeated 4 times a week, every other day. Invariably, the EEG response to TMS was 
characterized by a local, stereotypical positive–negative wave similar to those obtained during 
NREM sleep and anesthesia (Figure 2.3.1C, left). Interestingly, the same stimulation performed in 
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noncommunicative brain-injured patients capable of purposeful behaviors, such as visual tracking 
or response to simple commands (therefore diagnosed as MCS), was characterized by regaining a 
complex spatiotemporal pattern of cortical activations, closely resembling those obtained during 
wakefulness and REM sleep (Figure 2.3.1C, right). This similarity was even more explicit when 
TMS was performed in LIS patients, who were totally paralyzed except for vertical eye movements 
through which they could signal their awareness and establish a nonambiguous, functional 
communication with the external world. Along these lines, in a recent study, Ragazzoni and 
colleagues (Ragazzoni et al., 2013) reported reduced cortical connectivity following TMS in 
VS/UWS patients, as compared to MCS patients and healthy controls. 
2.3.1 - Consciousness and Complexity: From Theory to Practice 
Theoretical measures based on the idea that consciousness relies on the joint presence of 
differentiation and integration in neural systems have been proposed over the past decade (Seth et 
al., 2011; Tononi, 2008; Tononi et al., 1994). For example, neural complexity (Tononi et al., 1994) 
is high when small subsets of elements tend to show independence (differentiation), but large 
subsets show increasing dependence (integration). Φ (Tononi, 2008) is based on perturbing a 
system in all possible ways to count the number of different states (differentiation) that can be 
discriminated through causal interactions within the system as a whole (integration). A related 
measure, called causal density (Seth et al., 2011), is based on Granger causality and is high if a 
system’s elements are both globally integrated (they predict each other’s activity) and differentiated 
(they contribute to these predictions in different ways). Unlike other measures based on the 
entropy of spontaneous signals (Pincus et al., 1991), these theoretical measures share the insight 
that the kind of complexity that is relevant for consciousness should be based on the interactivity 
among different parts of the brain (Seth et al., 2008; Tononi, 2004). Unfortunately, the application 
of neural complexity, Φ and causal density to actual brains presents substantial practical 
challenges, such as extraordinary computational demands. 
The results outlined in the previous section demonstrated that during LOC the thalamocortical 
system, despite being active and reactive, loses its ability to engage in complex activity patterns 
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that are, at once, distributed within a system of interacting cortical areas (integrated) and 
differentiated in space and time (information-rich); it invariably either breaks down in casually 
independent modules (Massimini et al., 2005b) (loss of integration) or it bursts in an explosive 
response (Massimini et al., 2007) (loss of differentiation/information). The aforementioned 
TMS/EEG empirical measurements thus provide qualitative support to basic theoretical predictions 
and pave the way toward a quantification of brain complexity across subjects and conditions, a key 
requirement for a reliable, unified measurement scale. 
The Perturbational Complexity Index 
In order to capture brain complexity by means of a synthetic, quantitative index, have been recently 
developed a theory-driven empirical measure, the so called Perturbational Complexity Index (PCI), 
which can be practically employed at the patient’s bedside (Casali et al., 2013). In agreement with 
the relevant theoretical requirements for consciousness, PCI gauges the amount of information 
contained in the integrated response of the thalamocortical system to a direct perturbation. The 
idea is that the level of consciousness could be estimated empirically by perturbing the cortex 
(“zapping”) to engage distributed interactions and measuring the information content of the ensuing 
responses by algorithmic compressibility (“zipping”). Operationally, PCI is defined as the 
normalized Lempel–Ziv algorithmic complexity (Lempel and Ziv, 2006) of the overall 
spatiotemporal pattern of significant cortical activation measured by EEG and triggered by a direct 
cortical perturbation with TMS (Figure 2.3.2). In practice, PCI is expected to be low whenever 
causal interactions among cortical areas are reduced (loss of integration), since the matrix of 
activation engaged by TMS is spatially restricted; PCI will also be low if many interacting areas 
react to the perturbation, but they do so in a stereotypical way (loss of differentiation). In this case, 
the resulting matrix would be large but redundant and could be effectively compressed. It derives 
that PCI will be high only if the initial perturbation is transmitted to a large set of integrated areas 
that react in a differentiated way, giving rise to a complex spatiotemporal pattern of deterministic 
activation that cannot be easily reduced. 
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Figure 2.3.2 - Calculating the PCI. A binary spatiotemporal matrix of significant cortical activation triggered by 
TMS (green star) is compressed (“zipped”) by Lempel–Ziv algorithmic complexity. Modified from Casali et al 
(Casali et al., 2013). 
 
PCI was tested on a large data set of TMS-evoked potentials recorded in healthy subjects (N = 32) 
during wakefulness, dreaming, NREM sleep, and different levels of sedation induced by different 
anesthetic agents (midazolam, xenon, and propofol), as well as in a group of patients (N = 20) who 
emerged from coma and recovered consciousness to a variable extent. As shown in Figure 2.3.3A, 
experimentally, PCI was reproducible within and across subjects and depended exclusively on the 
level of consciousness in all conditions. Specifically, PCI was always high in wakefulness, 
irrespectively of TMS stimulation site and intensity, but dropped drastically when subjects lost 
consciousness in NREM sleep, after administration of midazolam, and during general anesthesia 
with propofol and xenon. In all these conditions, PCI was invariably reduced resulting in a clear-cut 
distinction between the distributions of the conscious and unconscious states. Crucially, PCI was 
as low as in NREM sleep and anesthesia in patients with a stable clinical diagnosis of VS/UWS, 
but was invariably higher in subjects who regained consciousness, including MCS, emerging from 
MCS (EMCS) and LIS patients (Figure 2.3.3B and 2.3.3C).  
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Figure 2.3.3 - Testing the PCI. (A) PCI values are shown for 152 TMS sessions collected from 32 healthy 
subjects. The histograms on the right display the distributions of PCI across subjects during alert wakefulness 
(dark gray bars) and loss of consciousness (LOC; light gray bars). PCI calculated during wakefulness (110 
sessions) ranged between 0.44 and 0.67 (mean = 0.55 ± 0.05), whereas the PCI calculated after LOC (42 
sessions) ranged between 0.12 and 0.31 (mean = 0.23 ± 0.04). (B) PCI values are shown for 48 TMS sessions 
collected from 20 severely brain-injured patients. PCI followed the level of consciousness (as clinically 
assessed with CRS-R) progressively increasing from VS/UWS through MCS and recovery of functional 
communication (EMCS) and attaining levels of healthy awake subjects in LIS. Patient results are directly 
compared with the ones obtained in healthy individuals. (C) Box plots for PCI in brain-injured patients are 
presented with the statistical significance between pairs of conditions (dashed black lines). *P < .005. **P < 
.0005. Modified from Casali et al (Casali et al., 2013). 
 
These results indicate that PCI provides an entirely data-driven metric that is reproducible across 
different conditions (wakefulness, dreaming, LIS, MCS, EMCS, NREM sleep, midazolam sedation, 
xenon and propofol anesthesia, VS/UWS) and comparable within and across single subjects in the 
same coordinate space. The main reason for this unprecedented result may reside in the fact that 
perturbational complexity gauges, at the same time, both the information content and the 
integration of brain activations. Indeed, PCI combines measures of algorithmic complexity with a 
perturbational approach, a method that detects large-scale activations that are intrinsically causal. 
Unlike other measures of complexity that are commonly applied to spontaneous brain signals, PCI 
accounts only for the information that is generated through deterministic interactions within the 
thalamocortical system. In this way, the resulting complexity is not affected by random processes, 
such as noise and muscle activity, or by patterns that are not genuinely integrated, such as the 
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ones generated by isolated neuronal sources or common drivers. Most important, PCI establishes 
a reliable measurement scale by defining a range of values between various conditions in which 
consciousness is known to be present (wakefulness, dreaming, LIS), and absent (NREM sleep, 
different types of anesthesia, stable diagnosis of VS/UWS). 
Finally, another clear advantage of this metric is the fact that it can be assessed on the basis of the 
complexity of cortical interactions, thus independent of the subjects’ capacity or willingness to react 
to external stimuli/commands. 
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CHAPTER 3 – CORTICAL BISTABILITY UNDERLIES 
PHYSIOLOGICAL AND PATHOLOGICAL LOSS OF 
CONSCIOUSNESS  
Why do complex, long-range cortical interactions collapse into a simple response whenever 
consciousness is lost? 
The striking similarity between TMS-evoked EEG responses during sleep, under anesthesia, and 
in VS/UWS patients suggests common neuronal mechanisms for LOC in these conditions. In all 
cases, the complex TMS-evoked activation observed during wakefulness is replaced by a 
stereotypical positive–negative deflection, which, when TMS is delivered at high intensities, 
evolves into a graphoelement that matches the EEG criteria for a sleep slow wave, or a K-complex 
(Massimini et al., 2007). Animal (Steriade et al., 2001) and human (Cash et al., 2009) intracranial 
recordings have shown that both spontaneous EEG sleep slow waves and K-complexes are 
underpinned by the occurrence of a silent, hyperpolarized down-state in cortical neurons, which is 
preceded and followed by a period of activation (up-state). This bimodal alternation between up- 
and down-states reflects an intrinsic bistability in thalamocortical circuits that is thought to depend 
on neuronal as well as network properties (Hill and Tononi, 2005; Mann et al., 2009; Sanchez-
Vives and McCormick, 2000; Timofeev et al., 2000, Sarasso et al., 2014). 
Our proposition is that, due to bistability, portions of the thalamocortical system, which are 
otherwise healthy, would not be able to sustain balanced patterns of activations; thus, the 
inescapable occurrence of a stereotypical down-state after an initial activation would prevent the 
emergence of complex, long-range patterns of activation in response to a direct stimulation. 
In order to test this hypothesis , experimentally, one should first demonstrate that the slow wave-
like graphoelement triggered by TMS during NREM, anesthesia and in VS/UWS patients truly 
reflect a neuronal down-state (i.e., a long lasting period of membrane hyperpolarization). To this 
aim, ideally, one could measure modulation of high-frequencies (gamma-range), which is 
considered a good proxy of the hyperpolarization of cortical neurons.  
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In the following paragraphs this problem has been addressed first from an intracerebral 
perspective, then using TMS/EEG. First, in the paragraph 3.1 the results obtained by Pigorini et al. 
are reported (Pigorini et al., 2015). Here intracranial electrical stimulation and recordings have 
been employed to demonstrate that during NREM sleep (a physiological model of LOC), a 
perturbation of thalamo-cortical system induced a widespread suppression of high frequencies (i.e. 
cortical downstates) that impairs the ability of thalamocortical circuits to engage in causal 
interactions, a theoretical requirement for consciousness (Tononi, 2004). Second, a recently 
submitted paper by Fecchio et al. is reported in the paragraph 3.2. Here, the results obtained 
invasively by using intracranial stimulation and recordings were confirmed non-invasively using 
TMS/EEG in NREM sleep. More important, they were extended at VS/UWS patients suggesting 
that bistability could be an important neurophysiological mechanisms underlying both physiological 
and pathological loss of consciousness. 
3.1 – Bistability breaks-off deterministic responses to intracortical 
stimulation during non-REM sleep 
Once awakened from NREM stage N3 early in the night people often deny that they were 
experiencing anything at all (Stickgold et al., 2001). Experimentally, this reduction of 
consciousness upon falling into NREM is associated with a significant impairment of the ability of 
distributed groups of cortical neurons to sustain reciprocal interactions. This alteration has been 
detected by analyzing functional connectivity within cortical networks in resting condition (Boly et 
al., 2012; Spoormaker et al., 2011; Tagliazucchi et al., 2013) and becomes obvious when one 
applies perturbations directly to the cerebral cortex. Hence, measurements performed with 
transcranial magnetic stimulation (TMS) and electroencephalography (EEG) have shown that a 
single magnetic pulse triggers a complex chain of causal interactions that propagate through a 
distributed network of cortical areas during wakefulness, but a simple response that remains either 
local (Massimini et al., 2005b) or spreads like an oil-spot (Massimini et al., 2007) during NREM. 
This altered response to TMS has been subsequently observed in other conditions in which 
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consciousness is lost, such as general anesthesia and the vegetative state (Casali et al., 2013; 
Rosanova et al., 2012). Also in these cases, a differentiated pattern of deterministic interactions is 
replaced by the occurrence of a stereotypical slow wave. Yet, the neurophysiological mechanisms 
underlying this reduction of the brain's capacity to sustain complex patterns of cortical activation 
remain unclear. 
The most obvious feature of spontaneous brain activity during NREM is the appearance of EEG 
slow waves associated with brief periods of hyperpolariziation and neuronal silence (down-states) 
(Steriade et al., 1993). In principle, the spontaneous occurrence of cortical down-states may in 
itself be enough to prevent reliable information transmission among cortical areas. However, while 
this mechanism may be crucial in the case of general anesthesia, during which cortical activity is 
frequently interrupted by long hyperpolarized down-states (Lewis et al., 2005), it may not be 
sufficient in other conditions such as sleep. In fact, intracellular recordings in cats show that even 
during deep NREM, cortical neurons can spend most of their time in a depolarized, wakefulness-
like up-state, which is only occasionally interrupted by hyperpolarized, silent down-states 
(Chauvette et al., 2011). Local field potentials (LFP) and multiunit recordings in humans have also 
demonstrated that most slow waves and the associated down-states are local (Hangya et al., 
2011; Nir et al., 2011), and that some brain areas may be active for long stretches while others are 
asleep (Nobili et al., 2011). Finally, the active periods observed during NREM share several 
fundamental features with ongoing activity during wakefulness, e.g. mean firing rate (Destexhe et 
al., 1999; Hobson and McCarley, 1971; Steriade et al., 2001), spectral profile (Csercsa et al., 2010) 
and synchronization level (Destexhe et al., 1999; Steriade and Amzica, 1996) so much so that the 
depolarized states of the sleep slow oscillation have been referred to as “fragments of 
wakefulness” (Destexhe et al., 2007, 1999). Thus, it is not obvious that the spontaneous 
occurrence of silent periods may substantially impair the brain's capacity for internal 
communication. 
Besides changes in spontaneous activity, cortical neurons undergo a more profound modification 
upon falling asleep as they become bistable upon changes in their intrinsic properties (Compte et 
al., 2003; Sanchez-Vives and McCormick, 2000; Timofeev et al., 2001). Due to underlying 
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bistability, cortical networks have the tendency to fall into a silent down-state in response to 
transient increases in activity (Compte et al., 2003; Sanchez-Vives and McCormick, 2000). An 
intriguing possibility is that this tendency may specifically impair the emergence of stable patterns 
of causal interactions among cortical areas. Specifically, we hypothesize that (i) during NREM a 
group of neurons that receives a cortical input rapidly plunges into a down-state and that (ii) this 
period of silence breaks-off the causal effects of the initial input. 
Intracranial single-pulse electrical stimulation (SPES) and simultaneous stereotactic EEG (SEEG) 
recordings offer a unique opportunity to test this hypothesis. First, intracranial recordings allow a 
reliable, although indirect, detection of cortical down-states as a significant suppression of high 
frequency power above 20 Hz in the LFP (Cash et al., 2009; Valderrama, 2012). Second, 
intracranial perturbations with SPES permit to assess cortico-cortical and/or cortico-subcortico-
cortical interactions from a causal perspective by calculating the phase locking factor (PLF) 
(Sinkkonen et al., 1995). We thus analyzed by means of time–frequency decomposition and 
phase-locking analysis the SEEG responses to SPES in 8 patients undergoing neurosurgical 
evaluation for intractable epilepsy. 
Materials and methods 
Patients and data acquisition 
Data included in the present study derived from a dataset collected during the pre-surgical 
evaluation of eight neurosurgical patients with a history of drug-resistant, focal epilepsy (Table 3.1). 
All subjects were candidates for surgical removal of the epileptic focus. During the pre-surgical 
evaluation all patients underwent individual investigation with simultaneous single pulse electrical 
stimulation (SPES) and recordings performed by stereotactically implanted depth multi-lead 
electrodes (Stereo-EEG, SEEG) for the precise localization of the epileptogenic zone and 
connected areas (Cossu et al., 2005). The investigated hemisphere, the duration of implantation 
and the location and number of stimulation sites were determined based on the non-invasive 
clinical assessment. 
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Table 3.1 Demographic and clinical information for each patient 
Subject 
Gender 
(Age, 
years) 
Medications 
(mg/day) 
Number of 
electrodes 
Number of contacts 
[after contact 
rejection] 
Epileptic zone 
location 
1 F (31) Carbamazepine 600 mg/day 17 189 [68] ** 
2 M (21) 
Levetiracetam 
3000 mg/day; Carbamazepine  800 
mg/day 
14 147 [64] 
Right central cingulate 
gyrus 
3 F (21) 
Levetiracetam 
3000 mg/day; Topiramate 
500 mg/day 
12 146 [44] 
Left posterior medial 
frontal gyrus 
4 M (36) 
Oxcarbamazepine 1200 mg/day; 
Phenobarbital 
100 mg/day; Lamotrigine 
150 mg/day 
14 170 [44] 
Right temporal 
neocortex 
5 M (31) 
Carbamazepine 800 mg/day; 
Phenobarbital 
100 mg/day; Levetiracetam 
3000 mg/day 
15 179 [58] Right orbital gyrus 
6 M (18) Carbamazepine 800 mg/day 14 165 [56] Right genus cinguli 
7 M (20) 
Carbamazepine 800 mg/day; 
Levetiracetam 
3000 mg/day 
14 186 [48] 
Right posterior mesial 
frontal gyrus 
8 M (25) 
Phenytoin 
400 mg/day; Topiramate 
500 mg/day 
12 143 [40] 
Right superior frontal 
gyrus 
**SEEG assessment in this patient was unrevealing (no contact showed interictal/ictal signatures). 
 
SEEG activity was recorded from platinum–iridium semiflexible multi-contact intracerebral 
electrodes, with a diameter of 0.8 mm, a contact length of 1.5 mm, an inter-contact distance of 2 
mm and a maximum of 18 contacts per electrode (Dixi Medical, Besancon France—Figures 
3.1.1A–B). The individual placement of the electrodes was ascertained by post-implantation 
tomographic imaging (CT) scans (Figure 3.1.1B). In addition scalp EEG activity was recorded from 
two platinum needle electrodes placed during surgery on the scalp at standard “10–20” positions 
Fz and Cz. Electro-ocular activity was recorded from the outer canthi of both eyes, and submental 
electromyographic activity was also recorded. Both EEG and SEEG signals were recorded using a 
192-channel recording system (NIHON-KOHDEN NEUROFAX-110) with a sampling rate of 1000 
Hz. Data were recorded and exported in EEG Nihon-Kohden format. Recordings were referenced 
to a contact located entirely in the white matter. 
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Figure 3.1.1. - Experimental setup and methods for SPES and recordings. Panel A. Outline of a multi-lead 
intracerebral electrode. Panel B. Sagittal and coronal sections of Subject 1 MRI showing an example of a multi-
lead intracerebral electrode (yellow rectangle). White dots identify recording contacts whereas a black triangle 
indicates the stimulation site. Panel C. Scalp EEG recorded during wakefulness (W-red) and NREM (NREM-blue) 
and concurrent raw intracerebral signal recorded from one bipolar contact (indicated by the yellow circle in 
Panel B). The first 5 s of each trace display spontaneous EEG activity followed by evoked responses to SPES 
(dashed lines and black triangles). Panel D. Percentage of contacts (± standard error) showing significant 
CCEPs during wakefulness (red) and NREM (blue). At the level of individual contacts, we tested different 
thresholds (from 2 to 14 standard deviation of the mean baseline activity) calculated from the rectified, mean 
amplitude of the CCEPs. Panel E. Colored traces represent single trials collected in W and NREM (red and blue 
respectively) at a given recording site (black circle onto the MRI coronal section of Panel B). Average responses 
are overlaid in black. The numbers and the arrows indicate the three components (1, 2 and 3) that characterize 
the response to SPES during NREM. 
 
SPES is a clinical procedure increasingly employed for the identification of abnormal cortical 
excitability in patients with epilepsy (David et al., 2010; Valentín et al., 2002). In the present 
dataset, SPES was performed five days after electrode implantation both during wakefulness and 
during NREM (Silber et al., 2007) given the possible nocturnal nature of the seizures. Specifically, 
a 5 mA current was applied through one pair of adjacent contacts, while SEEG activity was 
simultaneously recorded from all other bipolar contacts. A single stimulation session consisted of 
30 consecutive single pulses delivered at varying inter-stimulus intervals (1 to 5 s). The stimulation, 
recording and data treatment procedures were approved by the local Ethical Committee (protocol 
number: ID 939, Niguarda Hospital, Milan, Italy). All patients provided written informed consent. 
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Selection of recording contacts and stimulation session 
In each subject the dataset derived from the pre-surgical exploration included several sessions (up 
to 20), in which different contacts were stimulated, and multiple contacts (up to 189) were 
recorded. For the present analysis, selection of recording sites and stimulation sessions was based 
on the following criteria; we excluded from the analysis those contacts that (i) were located in the 
epileptogenic zone (as confirmed by post-surgical assessment), (ii) were located over regions of 
documented alterations of the cortical tissue (e.g. Taylor Dysplasia) as measured by the 
radiographic assessment, or (iii) exhibited spontaneous or evoked (Valentín et al., 2002) 
epileptiform SEEG activity during wakefulness or NREM (visual inspection performed by L.N. and 
P.P.). Also contacts located in white matter, as assessed by means of MRI, were excluded (by two 
of the authors: L.N. and C.S.) from further analysis. Anatomical locations of bipolar derivations 
were confirmed by means of customized MATLAB scripts, using Destrieux ATLAS. 
With the given contact selection, we analyzed the stimulation sessions that: (i) were delivered 
through a contact far from the epileptogenic zone (as confirmed by post-surgical assessment); (ii) 
were delivered through a contact that did not show spontaneous interictal activity (by visual 
inspection); (iii) did not evoke epileptic responses (Valentín et al., 2002) either in wakefulness or 
NREM; (iv) did not elicit muscle twitches, sensations or evident motor/cognitive effects (e.g. 
language comprehension/production or complex motor sequences) during presurgical evaluation, 
including single pulse and repetitive (50 Hz) stimulation (Cossu et al., 2005); (v) occurred during a 
period of N3 sleep; and (vi) did not disrupt sleep depth as assessed by comparing the power 
spectra of scalp EEG spontaneous activity before and after the stimulation train. If in a given 
subject more than one stimulation session fulfilled these criteria, we selected the one that triggered 
significant cortico-cortical evoked potentials (CCEPs, Matsumoto et al., 2004) in the largest 
number of contacts as in Keller et al. (2011). 
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Data preprocessing 
Data recorded during both wakefulness and NREM were imported from EEG Nihon Kohden format 
into Matlab and converted using a customized Matlab-based script. Data were subjected to linear 
detrend and bandpass filtering (0.5 – 300 Hz), using a third order Butterworth filter. Bipolar 
montages were calculated by subtracting the signals from adjacent contacts of the same depth-
electrode to minimize common electrical noise and to maximize spatial resolution (Cash et al., 
2009; Gaillard et al., 2009) (see Figure 3.1.1A). Single trials were obtained by using a digital trigger 
simultaneous to each SPES delivery. Finally, stimulation artifact was reduced by applying a Tukey-
windowed median filtering, as in Chang et al. (2012), between − 5 and 5 ms. 
Methodological rationale and data analysis 
First we assessed the number of contacts showing significant response to SPES by applying the 
same methodology as in Keller et al. (2011). Specifically, at the level of individual contacts, we 
tested different thresholds (from 2 to 14 standard deviations of the mean baseline activity) 
calculated from the rectified, mean amplitude of the CCEPs. Then, in order to assess quantitatively 
the differences in the dynamics triggered by SPES in wakefulness and NREM, we quantified (1) 
the amplitude of the low frequency components (< 4 Hz), (2) the suppression of high frequency 
power (> 20 Hz) and (3) the PLF. Indeed, these three measures indicate respectively the possible 
presence of SPES-evoked slow waves, the correspondent occurrence of a cortical down-state 
(Cash et al., 2009; Csercsa et al., 2010; Valderrama, 2012) induced by SPES and the causal 
effects of SPES at the level of individual contacts. In the following, as in previous works (Nir et al., 
2011; Vyazovskiy et al., 2009), we use the terms “OFF” periods instead of “down” (or 
“hyperpolarized”) states (Steriade et al., 2001) because silent periods were defined on the basis of 
extracellular activity (suppression of high frequency in the LFP) rather than based on a direct 
measure of membrane potential. 
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Amplitude of low frequency component 
To assess and quantify the presence of SPES-evoked slow waves we calculated, both for 
wakefulness and NREM, the amplitude of low frequency components (< 4 Hz) (Figure 3.1.2) for 
each contact as the average of absolute value of filtered (4 Hz low-pass, third order Chebyshev 
filtering) single trials. We rectified the slow components because slow waves could be either 
positive or negative, depending on contacts locations. Then we set to zero all the non-significant 
time points using a trial-based bootstrap statistical analysis (α < 0.01, number of permutations = 
1000) with respect to baseline (from − 300 ms to − 50 ms). 
High-frequency suppression 
To assess and quantify the presence of SPES-evoked cortical OFF-periods we calculated the 
amount of significant (bootstrap method; α < 0.05, number of permutations = 1000) high-frequency 
(> 20 Hz) suppression, an established extracellular marker of the neuronal down-state that 
characterizes sleep bistability (Cash et al., 2009; Csercsa et al., 2010; Mukovski et al., 2007; Nir et 
al., 2011; Valderrama, 2012; Vyazovskiy et al., 2009). Hence, as in Cash et al. (2009), we 
calculated for each contact the mean value of the ERSP above 20 Hz (Figure 3.1.2) over a peri-
stimulus time-window ranging between − 300 and + 700 ms. 
Phase locking factor 
To quantify and compare the duration of the deterministic effects of SPES during both wakefulness 
and NREM for each contact, the instantaneous PLF was calculated as in Palva et al. (2005). PLF 
is an adimensional (range 0–1) index defined as the absolute value of the average of the Hilbert 
Transform of all single trials; in the case of evoked potentials (here CCEPs), it reflects the ability of 
an external stimulus (here SPES) to affect the phase of ongoing oscillations across trials. 
Statistical differences from baseline (from − 300 ms to − 50 ms) were assessed (for each contact) 
by assuming a Rayleigh distribution of the values of the baseline. Then, given a statistical 
threshold set at α < 0.05, those PLF values below threshold were set to zero (Figure 3.1.2B). 
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Before calculating PLF, single trials were filtered (8–100 Hz) with a combination of high-pass and 
low-pass third-order Butterworth filters in order to minimize time-domain spread of PLF (Palva et 
al., 2005). To verify that the drop in PLF above 8 Hz was not trivially due to the absence of power 
in the same frequency range, we computed the average of the squared absolute value of filtered 
single trials (8 Hz high-pass, third order Butterworth filtering). Within the investigated frequency 
range, we also explored the contribution of the three classical EEG bands by measuring PLF of 
signals filtered in the alpha (8–13 Hz), beta (13–30 Hz) and gamma (above 30 Hz) ranges. 
 
 
Figure 3.1.2. - During NREM, SPES triggers a slow-wave-like response that is associated with high frequency 
suppression followed by decay of PLF. In Panel A the following measures are reported for three representative 
contacts in one subject. Location: the position of the stimulating contact is depicted (black triangle) over a 3D 
brain reconstruction (lateral view) of the individual's brain (Subject 1). Black circles and white circles show the 
position of three representative recording bipolar derivations from right and left hemisphere, respectively. 
CCEPs: the corresponding average responses from these contacts during wakefulness (W-red) and NREM 
(NREM-blue). As in Figure 3.1.1E, blue arrows and numbers indicate the three components of CCEPs evoked 
during NREM. SWa < 4 Hz: amplitude of the slow (< 4 Hz) wave component calculated as squared absolute value 
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of the CCEPs after 4 Hz low-pass third order Chebyshev filtering. After bootstrap statistic (α < 0.05), non-
significant time points (with respect to baseline, from − 300 to − 50 ms) were set to zero. ERSPs: time-frequency 
power spectra of CCEPs recorded in W and NREM. Time-frequency decomposition is applied at a single trial 
level using Wavelet Trasform (Morlet, 3 cycles) and significance for bootstrap statistics is set with α < 0.05. Blue 
color indicates a significant reduction compared to the baseline, while red indicates significant increase. The 
dashed horizontal line indicates 20 Hz. PWR > 20 Hz: time series of high frequency power (> 20 Hz). PLF > 8 Hz: 
PLF calculated on a single trial level both for W (red) and NREM (blue) after high-pass filtering (> 8 Hz). 
Statistical differences from baseline are assessed (for each contact) by assuming a Rayleigh distribution of the 
values of the baseline (from − 300 to − 50 ms). Then, given a statistical threshold set at α < 0.05, those PLF 
values below threshold were set to zero. Dashed vertical lines and triangles represent stimulus onset. Panel B. 
Same measures of Panels A but referred to a contact close to the stimulation site. 
Results 
In all patients (Table 3.1) SPES was delivered both during wakefulness and NREM through one 
pair of adjacent (2 mm apart) contacts pertaining to the same depth-electrode, while SEEG 
recordings were obtained from all other bipolar contacts (Figures 3.1.1A–B; see Materials and 
methods for a detailed description of the number and location of the stimulating and recording 
contacts). In each individual, depending on clinical needs, a number of cortical sites were 
stimulated with 30 pulses at frequencies between 0.2 and 1 Hz during wakefulness preceding 
lights off as well as during NREM (scored according to Silber et al., 2007). Off-line sleep scoring 
using one scalp EEG derivation, together with one bipolar electrooculographic (EOG) and one 
electromyographic (EMG) derivation confirmed that all considered sessions were recorded during 
NREM N3. The stability of stage N3 throughout each stimulation session was further assessed by 
comparing the power spectra of the scalp EEG recorded immediately (40-s epochs) before and 
after the SPES train. 
As illustrated in Figure 3.1.1C, CCEPs were highly reproducible from trial to trial and were 
characterized by a high signal-to-noise ratio in intracranial recordings. As a first step, we asked 
whether the ability of SPES to trigger significant activations across recording contacts differed in 
NREM compared to wakefulness. To do so, we detected at each contact the presence of 
significant CCEPs employing the same criteria described by Keller et al. (2011); for each individual 
contact, we tested different thresholds applied to the rectified amplitude of the CCEPs calculated 
on the mean amplitude signal. Across patients, the percentage of significantly active contacts in 
both wakefulness and NREM decreased monotonically with increasing thresholds (from ~ 100% at 
2SD to ~ 50% at 14SD) and tended to be lower during NREM (Figure 3.1.1D). However, no 
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significant difference was observed between the two conditions at any applied threshold. Despite 
this similarity in the number of contacts affected by the initial stimulation, the CCEPs recorded 
during wakefulness and NREM were substantially different in terms of their wave shape. 
SPES evokes a slow wave-like response in NREM but not in wakefulness 
Generally, during wakefulness SPES evoked a composite response made of recurrent waves of 
activity that persisted until ~ 500 ms (Figure 3.1.1E). Conversely, during NREM, CCEPs consisted 
of a simpler and slower wave, composed of three consecutive events, which we will henceforth call 
components 1, 2 and 3 (Figures 3.1.1E and 3.1.2). The polarity of these components could be 
inverted depending on the location of the recording contacts. In all cases, component 1 was a 
sharp peak (between 10 and 50 ms), component 2 was a prominent rebound of opposite polarity 
(peaking ~ 200 ms), and component 3 was an ensuing, smoother deflection in the same direction 
as component 1. Quantitatively, cortical responses to SPES during NREM were characterized by a 
prevalent low frequency (0.5–4 Hz) oscillation that was invariably reduced during wakefulness 
(Figure 3.1.2A). Overall, both in terms of period and peak amplitude, the CCEPs recorded during 
NREM closely resembled spontaneously occurring sleep slow waves. 
SPES induces suppression of high-frequency power in NREM but not in wakefulness 
To further explore the relationships between the CCEPs obtained during NREM and sleep slow 
waves, we capitalized on previous animal and human intracranial recordings. These studies show 
that the silent hyperpolarized state that characterizes the cortical OFF-period of spontaneously 
occurring sleep slow oscillations is marked by a suppression of high-frequency power (> 20 Hz) in 
the LFP (Amzica and Steriade, 2002; Cash et al., 2009; Csercsa et al., 2010; Mukovski et al., 
2007; Nir et al., 2011; Steriade et al., 1993). Hence, we performed time–frequency decomposition 
of CCEPs (Cash et al., 2009) to compare the power modulation (as assessed by event-related 
spectral perturbation—ERSP) during wakefulness and NREM. Results obtained in one patient at 
three representative cortical targets during wakefulness and NREM are shown Figure 3.1.2A. 
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While the composite CCEPs recorded during wakefulness corresponded to increases in spectral 
power as compared to baseline, the slow wave-like response elicited in NREM was associated with 
an alternation of positive and negative significant power modulations (see Methods, bootstrap 
statistics, α < 0.05). Specifically, component 1 of the NREM response coincided with a transient 
broad-band increase of spectral power. Component 2 was associated with a significant 
suppression of high-frequency oscillations (> 20 Hz) (Figure 3.1.2), irrespective of stimulation 
frequency and of the level of background activity. Finally, during component 3 spectral power 
recovered and rebounded to a level comparable to wakefulness in a broad range of frequencies 
(between 8 Hz and 100 Hz), including alpha, spindle and beta rhythms (Figure 3.1.2A). 
Phase-locking is short-lasting during NREM but sustained during wakefulness 
Next, we tested our main hypothesis, i.e. that bistability break-off the causal effect of cortical inputs 
during NREM. To quantify and compare the duration of the deterministic effects of SPES during 
both wakefulness and NREM, we employed PLF applied to the LFP activity in the 8–100 Hz 
frequency band, the same range characterizing (i) wakefulness activity (Steriade et al., 2001; 
Timofeev et al., 2001), (ii) cortical activity during the up-state of spontaneous sleep slow oscillation 
(Destexhe et al., 2007; Mölle et al., 2002; Steriade, 2006), and (iii) the power increase observed, in 
our experiment, during component 3 of the NREM response (see Figure 3.1.2A). As shown in 
Figure 3.1.2A, compared to wakefulness, NREM CCEPs were characterized by an early 
dampening of PLF, which remained below significance level (Rayleigh, α < 0.05) throughout 
component 3, despite the persistence/recovery of power in the 8–100 Hz range ( Figure 3.1.2A). 
Notably, during wakefulness PLF was long lasting and remained significant until ~ 500 ms even for 
the few contacts adjacent to the stimulation site, which reacted with a slow wave and a 
suppression of high frequency similar to NREM ( Figure 3.1.2B). 
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Amplitude, power and phase-locking modulations of cortical responses are reproducible 
across contacts and patients 
Overall, the results obtained for low frequency amplitude, high-frequency power suppression, 
duration of PLF and their differences between wakefulness and NREM were reproducible across 
cortical contacts (Figure 3.1.3B), significant across contacts at the single subject level (Figure 
3.1.3B, histograms—Wilcoxon ranksum test, p < 0.05) and consistent at the population level 
(Figure 3.1.3C—Wilcoxon ranksum test, p < 0.05). Hence, cortical responses to SPES during 
NREM were characterized by a prominent low frequency (0.5–4 Hz) oscillation, by a significant 
suppression of high-frequency (20–100 Hz) activity and by an early (~ 200 ms) obliteration of 
phase-locked, deterministic effects. By contrast, during wakefulness, when the low frequency 
component was reduced and the suppression of high frequency was absent, the PLF remained 
significant until ~ 500 ms after SPES. 
 
Figure 3.1.3. - Amplitude, power and phase-locking modulation are consistent across contacts and subjects. 
Panel A: for the same representative subject, color coded plots of amplitude of the slow (< 4 Hz) wave 
component, high frequency power (> 20 Hz) and PLF (> 8 Hz) are calculated as a function of time for all contacts 
both for wake (W—left column) and NREM (NREM—right column). For each plot the responses to SPES are 
ranked based on the amount of low frequency power during NREM. Panel B. On the left, the same three 
measures as in Panel A averaged across contacts for W (in red) and NREM (in blue). On the right, the top and 
the middle histograms indicate the average values for low frequency amplitude and high frequency power 
respectively (black bars indicate standard error of the mean) calculated over the time interval between − 50 ms 
and + 50 ms around the maximum of the low frequency wave detected at each contact (Panel A—top left box). 
The bottom histogram shows the average duration of phase-locking (black bars indicate standard error of the 
mean) calculated from the time of the latest statistically significant non-zero PLF for each contact, in W and 
NREM. ** indicates significant differences (Wilcoxon ranksum test p < 0.01). Panel C. The same three measures 
shown in Panels A and B are tested across all subjects (W in red, NREM in blue). Black lines indicate the grand 
average across subjects. Black vertical bars indicate the standard errors. Differences between W and NREM at 
the population level were tested using a Wilcoxon ranksum test (p < 0.01) and were significant for all three 
measures. 
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Amplitude, power and phase-locking modulations of cortical responses are related during 
NREM 
We finally asked whether the three distinctive features of the NREM response (i.e. the presence of 
a slow wave-like response, high frequency suppression and shorter PLF duration) were related. To 
this aim, for each subject, we selected the contacts showing the largest (top 50%) power in the 
slow wave frequency band (0.5–4 Hz). We then computed (i) the correlation between the maximum 
amplitude of the evoked slow wave (max SWa) and the maximum level of suppression of high-
frequency power with respect to baseline (max SHFp) as well as (ii) the correlation between the 
timing of the maximum high frequency suppression (max SHFt) and the latency at which PLF 
dropped below significance level (max PLFt). This analysis detected significant correlations in each 
single subject showing (i) that larger evoked slow waves corresponded to more pronounced 
suppressions of high frequencies and (ii) that earlier suppressions corresponded to an earlier 
dampening of PLF (Figure 3.1.4). 
 
 
Figure 3.1.4. - Amplitude, power and phase-locking modulation are related during NREM. Panel A. For each 
subject the correlation between the maximum amplitude (converted in dB) of the evoked slow wave (max SWa) 
and the maximum level of high-frequency power suppression with respect to baseline (max SHFp) is shown. 
Below, the coefficient of determination R2 and the significance level p of the correlation are indicated for each 
subject. Panel B. For each subject the correlation between the timing of the maximum high frequency 
suppression (max SHFt) and the latency at which PLF fell below the threshold for significance (max PLFt) is 
shown. Below, the coefficient of determination R2 and the significance level p of the correlation are indicated for 
each subject. For each subject, both correlations were calculated considering the contacts that showed the 
highest (top 50%) low frequency amplitude during NREM. 
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Discussion 
In the present work we compared CCEPs recorded during wakefulness and NREM by means of 
time–frequency analysis and PLF in 8 epileptic patients implanted with SEEG electrodes for clinical 
evaluation. We observed that during wakefulness SPES triggers a chain of sustained effects, as 
indicated by a phase-locked response that lasted for about half a second. During NREM the same 
initial activation induces a slow wave and a cortical OFF-period in its cortical targets after which the 
phase-locked response breaks-off, in spite of restored levels of cortical activity. 
Bistability, cortical down-states and break-off of phase-locked responses 
Intracortical stimulation/recordings can be used to study cortico-cortical interactions from a causal 
perspective. SPES delivered to the grey matter is thought to elicit direct depolarization of the initial 
segment of the axons, which travels through direct or indirect cortico-cortical pathways generating 
CCEPs in adjacent and remote areas (Keller et al., 2011; Matsumoto et al., 2004). Accordingly, in 
the present work, we observed evoked responses to SPES in targets both near and far from the 
stimulating contact, in ipsi-lateral and contro-lateral areas (see Figure 3.1.2A). Significant 
responses to SPES could be elicited in a large number of contacts during both wakefulness and 
NREM (Figure 3.1.1D). This finding is in agreement with previous animal studies (Richardson and 
Fetz, 2012) and with the hypothesis that the breakdown of complex interactions observed during 
NREM by means of TMS/EEG is not due to the interruption of structural cortico-cortical and/or 
cortico-subcortico-cortical connections but rather to changes in the dynamics of neuronal 
responsiveness (Massimini et al., 2012). Indeed, we observed that the initial activation triggered by 
SPES in its cortical targets was followed by a composite set of waves during wakefulness, but by a 
stereotypical slow wave that was associated with an extracellular marker of a neuronal down-state 
during NREM. Interestingly, slow waves and cortical OFF-periods could be triggered even on the 
background of a low-amplitude, wakefulness-like activated LFP. This observation is consistent with 
in vivo and in vitro studies showing that, due to bistability, networks that can display wakefulness-
like activity tend to fall into a silent down-state upon transient increases in activation (Compte et al., 
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2003; Sanchez-Vives and McCormick, 2000; Timofeev et al., 2001). At the neuronal level, the 
bistability of NREM sleep is thought to be primarily due to the dynamics of activity-dependent 
potassium (K +) currents, which become prominent when the neuromodulating milieu changes 
upon falling asleep (Compte et al., 2003; Sanchez-Vives and McCormick, 2000; Timofeev et al., 
2001). In this condition, the stronger is the initial activation, the more K +-currents will tend to drive 
neurons into a hyperpolarized, silent state (Compte et al., 2003). Accordingly, in the present study, 
the degree of high frequency suppression was significantly correlated with the amplitude of the 
SPES-evoked potentials (Figure 3.1.4A), indicating that larger responses were associated with 
stronger OFF-periods (i.e deeper down-states). 
We also found that the timing of the occurrence of the OFF-period was correlated with the timing of 
the drop of PLF (Figure 3.1.4B) pointing to a specific role of the down-state in the early disruption 
of causal interactions. Importantly, PLF values dropped below significance level after the OFF-
period despite power recovering to levels comparable to wakefulness in the 8 to 100 Hz frequency 
band. Different neuronal mechanisms may account for this phenomenon. Indeed, in vivo, in vitro 
and in computo studies seem to suggest that the resumption of cortical activity after the silent 
down-state of the slow oscillation is a stochastic process (Chauvette et al., 2011; Compte et al., 
2003; Sanchez-Vives and McCormick, 2000) possibly due to spontaneous neurotransmitter 
release (Timofeev et al., 2000), intrinsic properties leading to spontaneous firing of layer V neurons 
(Sanchez-Vives and McCormick, 2000), or selective synchronization of small neuronal ensembles 
(Cossart et al., 2003; Luczak et al., 2007). 
An additional finding that is worth discussing is that the PLF measured during wakefulness 
remained significant up to ~ 500 ms even in the contacts adjacent to the stimulation site, which, 
unlike distant targets, displayed a large slow wave with a concurrent significant suppression of high 
frequency activity, possibly due to the local paraphysiological effects of intracranial electrical 
stimulation (Borchers et al., 2012). A plausible explanation for the persistence of deterministic 
effects induced by SPES following this local OFF-period is the feedback of phase-locked activity 
from the rest of the network during wakefulness. A recent study employing cortical microstimulation 
in the monkey visual cortex demonstrated that, while feed-forward interactions mainly occur in the 
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gamma band, feed-backs are carried by alpha oscillations (Van Kerkoerle et al., 2014). 
Interestingly, in the present study we found that phase-locking in the gamma band was short-
lasting (~ 70 ms) and comparable between wakefulness and NREM, whereas phase-locking in the 
beta and alpha bands was sustained (~ 500 ms) only during wakefulness. In future studies it will be 
important to elucidate the relative contribution of feed-forward versus feed-back network dynamics 
to the persistence of phase-locking during wakefulness as compared to NREM. 
Bistability and loss of consciousness 
Growing evidence suggest that the sleeping brain can still process sensory inputs at least to some 
extent (Bastuji et al., 2002; Kouider et al., 2014) and that it can actively support restorative 
functions (Tononi and Cirelli, 2014) and memory consolidation (Destexhe et al., 2007; Inostroza 
and Born, 2013). Indeed, compared to general anesthesia, during which a saturation of slow waves 
(Purdon et al., 2013) and frequent down-states may lead to a complete fragmentation of neuronal 
networks (Lewis et al., 2012), the impairment of cortico-cortical and/or cortico-subcortico-cortical 
interactions indicated by the present measurements in NREM is more likely to be relative and 
graded. In practice, the dynamics revealed by SPES point to a general mechanism by which the 
brain's potential to sustain large-scale, specific patterns of causal interactions may be impaired 
during NREM compared to wakefulness; due to bistability cortical circuits, upon receiving an input, 
tend to respond briefly, then hush and forget. We argue that, while this dynamics still allows a 
certain degree of deterministic interactions, it may specifically affect the level of consciousness. 
For example, stimulation (Libet, 1982) as well as recording (King et al., 2014) experiments in 
humans have shown that conscious perception requires the activity of cortical neurons to be stable 
in time for hundreds of milliseconds. The occurrence of a cortical OFF-period (i.e. down-state) 
observed here as early as 100 ms after SPES, may act on this time factor by curtailing the duration 
of stable neuronal responses. At the network level, bistability may interfere directly with the efficacy 
of recurrent processes among distributed cortical areas, another mechanism that is thought to be 
important for consciousness (Lamme et al., 1998; Tononi and Edelman, 1998). To the extent that 
reentry relies on the amplification of coherent activity across distributed set of neurons, the 
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scrambling of phases operated by the down-states at each node may critically impair the 
emergence of this large-scale phenomenon (Lumer et al., 1997). Finally, the present data fit nicely 
with the postulate that consciousness depends on the brain's ability to integrate information which, 
in turn, relays on effective information (EI) among different group of neurons (Hoel et al., 2013). EI 
is a perturbation-based general measure of causal interactions that captures how effectively 
causes produce effects in the system and how selectively causes can be identified from effects. 
Thus, EI is maximal for systems that are deterministic (i.e. a given initial state produces a given 
effect) and not degenerate (i.e. different initial states produce different effects); EI decreases with 
degeneracy (i.e. different initial states produce the same effect) and/or indeterminism (i.e. when a 
given initial state produce different effects) (Hoel et al., 2013). Our results suggest that, when 
cortical neurons become bistable, any input invariably converges into a stereotypical down-state 
(degeneracy), after which the causal effects of the input are obliterated (loss of determinism). 
In this perspective, cortical bistability seem to be in a key position to selectively impair the level of 
consciousness. 
Practically, the present results provide a mechanistic account for the collapse of complex 
spatiotemporal interactions revealed by non-invasive TMS/EEG experiments during NREM and 
other conditions (Casali et al., 2013). A particularly interesting possibility is that bistability may play 
a role in pathological states in which TMS invariably triggers a stereotypical EEG slow wave, such 
as the vegetative state/unresponsive wakefulness syndrome (Casali et al., 2013; Rosanova et al., 
2012). Indeed, brain lesions may indirectly induce bistability in intact cortical tissue in several ways 
such as by (i) impairing the function of brainstem activating systems, thus enhancing K+-
conductances at the cortical level (Englot et al., 2010), by (ii) reducing the excitatory drive of 
thalamostriatal circuits on cortical neurons (Schiff, 2010), by (iii) altering the excitation/inhibition 
balance in favor of inhibition (Murase et al., 2004), and by (iv) severing subcortical white matter 
fibers (Timofeev et al., 2000). To the extent that bistability—a process that is in principle 
reversible—is involved in these conditions, it may represent a suitable target for novel therapeutic 
approaches in patients in whom consciousness is impaired despite preserved cortical activity. 
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Limitations 
Our observations were derived from a population of epileptic patients whose clinical condition and 
ongoing treatment may affect the SEEG recordings. To minimize this confound, our results did not 
include any contact (i) located in the epileptic zone as verified by surgical resection, (ii) located 
over regions of documented structural brain damage, nor (iii) exhibiting interictal activity (see 
Material and methods). 
Another potential limitation is that our data did not include multi-unit activity recordings, thus 
preventing a direct observation of neuronal silence. However, previous studies in animals 
(Mukovski et al., 2007; Vyazovskiy et al., 2009) and humans (Cash et al., 2009; Csercsa et al., 
2010; Nir et al., 2011) have provided solid evidence that the typical down-state characterized by 
sleep slow oscillations can be reliably detected based on spectral modulation in the high-frequency 
(20–100 Hz) range of the LFP signal. 
The number of session and recording contacts included in this study was constrained by clinical 
needs and exclusion criteria. However, the recording contacts included in the present analysis 
showed a widespread distribution across the cerebral cortex and the stimulations were applied to 
different cortical areas including frontal, parietal, cingular and insular cortex. Thus, while we cannot 
rule out specific regional differences that may only become significant through a more intensive 
and systematic mapping of CCEPs during wakefulness and sleep, we may safely conclude that our 
results could be generalized to different cortical areas. 
Finally, it is known that awakening from NREM sleep (especially stages N1 and N2) and from 
Rapid Eyes Movement sleep (REM) result in dream report (McNamara et al., 2010). Although 
bistability per se does not index directly the level of consciousness, it would be important to assess 
its degree in all these conditions. In the present work we focused on comparing the responses 
obtained during wakefulness and N3 early in the night because (1) our primary goal was to parallel 
previous experiments employing non-invasive stimulation and recordings with TMS/EEG, (2) 
because we observed that NREM sleep N2 was less stable and much more affected by 
spontaneous interictal activity and paraphysiological pattern compared to N3 and (3) because, 
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since we couldn't wake up subjects to obtain a report during the clinical protocol, we capitalized on 
previous works showing that the most extreme reduction of conscious experience occurs during 
the first N3 episode of the night (McNamara et al., 2010; Stickgold et al., 2001). This specific focus 
represents a limitation of this study and future works should definitively try to assess differences 
among sleep stages with special regards on REM sleep. 
3.2 – Sleep-like cortical bistability in vegetative state patients 
The results presented in paragraph 3.1 reveal a general neurophysiological mechanism (bistability 
and the associated down-states) by which reliable deterministic interactions within thalamo-cortical 
system may be impaired even in the presence of intact cortical connections and preserved levels 
of neuronal activity. In essence, cortical circuits, upon receiving an input, tend to respond briefly, 
then hush and forget. In this paragraph has been presented a study that investigate whether the 
same mechanism may account for the collapse of thalamo-cortical complexity detected by 
TMS/EEG in pathological conditions such as the vegetative state/unresponsive wakefulness 
syndrome. 
Materials and methods 
Study participants 
Twenty-one severely brain-injured patients (8 females; mean age±SD: 53.47±21.47) and thirty-
three healthy subjects (14 females; mean age±SD: 28.93 ±7.56) participated in the study. Patients 
were diagnosed as VS (n=13) and MCS (n=8) by means of the Coma Recovery Scale-Revised 
(CRS-R)(Giacino et al., 2004). In order to avoid diagnostic errors due to fluctuations in 
responsiveness and to obtain a stable clinical diagnosis, nineteen out of twenty-one patients 
underwent CRS-R assessments four times a week, every other day. The remaining two patients 
(Patient 20 and 21 of Table 3.2) were recruited from intensive care and underwent longitudinal 
behavioral and TMS/EEG assessments as they awakened from coma and progressed towards 
recovery of consciousness evolving from a VS, through a MCS to emergence from the MCS 
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(EMCS). The VS and MCS subgroups of patients did not systematically differ in etiology and time 
from injury. In Table 3.2 single patient’s details about etiology and CRS-R performed before the 
TMS/EEG experiment are reported.  
Study design 
All study participants underwent at least one TMS/EEG session during wakefulness. Eight healthy 
subjects and participated in one TMS/EEG session during sleep. Patients 20 and 21 that 
underwent longitudinal assessments, three TMS/EEG sessions (Session 1, Session 2 and Session 
3) were performed as they awakened from coma and progressed towards different clinical states 
(see Study participants). Session 1 was performed at least 48 h after withdrawal of sedation, when 
patients exited from coma and entered the VS. In these subjects who recovered, Session 2 was 
performed on the day after they transitioned from VS to MCS (however, Patient 21 temporarily 
slipped back into a vegetative state); Session 3 was performed after they regained functional 
communication and emerged from a minimally conscious state (emergence from minimally 
conscious state). The experimental procedures were approved respectively by the ethical 
committees of the Medicine Faculty of the University of Liège, Niguarda Hospital and Institute Don 
Gnocchi for the patients and by Hospital Luigi Sacco for the healthy subjects. 
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Table 3.2 Clinical information 
 
Clinical features CRS-R 
Patient 
Gender 
(age, 
years) 
Etiology 
Time of 
TMS/EEG 
(days after 
insult) 
Diagnosis 
at time of 
TMS/EEG 
Auditory 
function 
Visual 
function 
Motor 
function 
Oromotor/ 
Verbal 
function 
Communication Arousal Total score 
1 M (81) CVA 19 VS 0 0 2 1 0 2 5 
2 M (68) Trauma 21 VS 0 0 2 0 0 2 4 
3 F (83) Trauma 6 VS 1 0 1 0 0 1 3 
4 M (19) Trauma 172 VS 1 0 1 1 0 2 5 
5 F (77) Subarachnoid hemorrhage 44 VS 1 0 2 1 0 1 5 
6 M (67) Hemorrhage 247 VS 2 0 1 1 0 2 6 
7 M (34) CRA 7809 VS 1 1 2 1 0 2 7 
8 F (19) Trauma 1316 VS 1 1 1 2 0 1 6 
9 M (55) CVA 50 VS 2 1 0 0 0 2 5 
10 M (57) CRA 895 VS 1 0 2 1 0 2 6 
11 F (44) CVA 2891 VS 1 0 2 2 0 2 7 
12 M (28) Trauma 2410 MCS 2 3 5 2 0 2 14 
13 F (76) Subarachnoid hemorrhage 28 MCS 1 3 2 2 0 2 10 
14 M (72) CVA 38 MCS 3 5 2 2 1 1 14 
15 M (20) Trauma 1334 MCS 3 3 1 1 0 2 10 
16 F (38) Trauma 12 MCS 3 3 5 2 1 1 15 
17 M (62) Subarachnoid hemorrhage 20 MCS 1 3 2 1 0 2 9 
18 M (32) CRA 35 MCS 2 3 5 2 0 2 14 
19 M (71) CVA 18 MCS 2 2 5 2 0 2 13 
20 F (60) CVA 
15 VS 0 0 2 2 0 1 5 
23 MCS 3 0 2 1 1 1 8 
31 EMCS 4 5 6 2 2 1 20 
21 F (60) CVA 
35 VS 0 0 1 1 0 1 3 
46 MCS 3 1 1 1 0 1 7 
56 EMCS 3 3 4 3 2 1 16 
CRA cardio respiratory arrest, CVA cerebrovascular accident 
Transcranial Magnetic Stimulation targeting and stimulation parameters 
A single TMS/EEG session consisted in different measurements that differed either for the site or 
the intensity of stimulation.  
Patients’ cortical targets were identified on CT or structural MRI scans acquired respectively with a 
Siemens Senatom Sensation 16 and a using a 3T scanner. In healthy subjects TMS targets were 
identified on anatomical magnetic resonance imaging (MRI) scans that were acquired using a 3T 
scanner. We employed a Focal Bipulse figure-of-eight coil for the stimulation (mean/outer winding 
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diameter ~50/70 mm, biphasic pulse shape, pulse length ~280 ms, focal area of the stimulation 
0.68 cm2) driven by a Mobile Stimulator Unit (eXimia TMS Stimulator, Nexstim Ltd.). We controlled 
TMS parameters by means of a Navigated Brain Stimulation (NBS) system (Nexstim Ltd.) that 
employed a 3D, frameless infrared tracking position sensor unit to locate the relative positions of 
the coil and subject’s head within the reference space of individual CT or MRI scans. NBS 
estimates online, the distribution and the intensity (expressed in V/m) of the intracranial electric 
field induced by TMS. The location of the maximum electric field induced by TMS on the cortical 
surface (hot spot) was always kept on the convexity of the targeted gyrus with the induced current 
perpendicular to its main axis. At least 300 trials were collected for each stimulation site. 
Stimulation was delivered with an interstimulus interval randomly jittering between 2000 and 2300 
ms (0.4–0.5 Hz), at an intensity ranging from 90 V/m up to 200 V/m on the cortical surface, that is 
largely above the threshold (50 V/m) for a significant TMS/EEG response (Casali et al., 2010; 
Komssi et al., 2007). The CT/MRI-guided intracranial electric field estimation is a crucial step 
during the experimental procedure; due to shifts of intracranial volumes in brain-injured patients, it 
is difficult to assess whether TMS is on target and effective based on extra-cranial landmarks alone 
and this may result in false-negatives (absence of EEG response due to missed target or sub-
threshold stimulation)(Gosseries et al., 2015). NBS also guaranteed the reproducibility of the 
stimulation coordinates, within and across sessions in Patient 20 and 21, as it indicates, in real-
time, any deviation from the designated target >3 mm.  
By means of the NBS, TMS was targeted to the premotor and the posterior parietal cortex as well 
as its interactions with more frontal areas, is thought to be particularly relevant for consciousness 
(Laureys et al., 2004). In practice, all cortical sites were not always accessible in all patients due to 
skull breaches or external drain derivations. In these cases, we avoided stimulating over focal 
cortical lesions that were clearly visible in CT scans, since the EEG response of these areas may 
be absent or unreliable (Gosseries et al., 2015). 
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EEG recordings 
TMS-evoked EEG measurements were recorded using a TMS compatible 60-channel amplifier 
(Nexstim). This device prevents amplifier saturation and reduces, or abolishes, the magnetic 
artefacts induced by the coil’s discharge (Virtanen et al., 1999). The EEG signals were referenced 
to a forehead electrode, filtered (0.1-500 Hz), and sampled at 1450 Hz. Two additional sensors 
were applied to record the electro-oculogram (EOG). In the present experiments, as in previous 
studies, in order to abolish the evoked auditory potentials due to the click associated with the TMS 
discharge, a sound masking the TMS click was generated and played via earphones throughout 
the TMS/HD-EEG sessions.  
During off-line data processing, an automatic algorithm was used in order to reject all trials that 
contained spontaneous blinks, eye movement, or muscle artefacts (Casali et al., 2010). After 
artefact rejection, 86 good TMS/EEG measurements were further analyzed and were included in 
the present study. For each patient we considered a single TMS/EEG measurement per area 
based on the maximum intensity of stimulation, for a total of 38 TMS/EEG session (9 premotor and 
11 parietal in VS patients, 9 in premotor and 9 in parietal in MCS patients) in patient population, 40 
TMS/EEG session (20 premotor and 20 parietal) for awake healthy subjects and 8 during sleep (3 
premotor and 5 parietal). 
General experimental procedures 
During the experiment, patients were lying on their beds, awake and with their eyes open. If signs 
of drowsiness appeared, recordings were momentarily interrupted and subjects were stimulated 
using the CRS-R arousal facilitation protocols. Each healthy subject was sitting in an adjustable 
chair with a headrest that ensured a stable head position. As for patients, healthy subjects were 
asked to keep their eyes open to ensure wakefulness throughout the recording sessions. The 
stability of the stimulation coordinates was continuously monitored throughout all acquisitions by 
means of the NBS system. If the virtual aiming device was signaling a displacement from the 
cortical target greater than 4 mm, the TMS/EEG measurement was interrupted and the coil was 
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repositioned. At the end of the experiment, the stimulation coordinates were recorded and the 
electrode positions were digitized. 
Data analysis and statistic 
Data analysis was performed using Matlab R2012a (The MathWorks). TMS/EEG trials containing 
noise, muscle activity or eye movements were automatically rejected (Casali et al., 2010) and then 
visually inspected for an additional check. After that, EEG data were band-pass filtered (1-45 Hz), 
down-sampled to half of the original sampling rate (725 Hz) and then segmented in window of ± 
600 ms around the stimulus. Then, trials were average referenced and baseline corrected over 500 
ms prestimulus. Independent component analysis (ICA) was then applied in order to remove 
residual artifacts. Each TMS-evoked response was obtained by averaging 100-250 artifact-free 
trials. 
Methodological rationale and data analysis 
In order to assess quantitatively the differences in the dynamics triggered by TMS in patients and 
healthy subjects, we quantified (1) the amplitude of the low frequency components (< 4 Hz), (2) the 
suppression of high frequency power (> 20 Hz) and (3) the phase locking factor (PLF). Indeed, 
these three measures indicate respectively the possible presence of TMS-evoked slow waves, the 
correspondent occurrence of a cortical down-state (Cash et al., 2009; Csercsa et al., 2010; Pigorini 
et al., 2015; Valderrama, 2012) induced by TMS and the causal effects of TMS at the level of 
individual EEG electrode.  
Analysis of TMS/EEG measurements in the frequency domain 
We calculated in order to assess and quantify the presence of TMS-evoked slow waves the 
amplitude of low frequency components (< 4 Hz) for each electrode as the absolute value of 
filtered (4 Hz low-pass, third order Chebyshev filtering) evoked response after re-referencing to the 
mathematically linked mastoids. We re-referenced the TMS-evoked response to the mastoids 
because the slow components in the single channels average referenced could be either positive 
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or negative. Then, the amplitude of low frequency component was calculated by the integral of the 
signal from 8 to 350 ms. In order to calculate the EEG high frequency (>20 Hz) power suppression 
to assess and quantify the presence of TMS-evoked cortical OFF-periods, an established 
extracellular marker of the neuronal down-state, TMS evoked potentials were analyzed using 
newtimef, an EEGlab function. Specifically, time-frequency decomposition using Wavelet transform 
(Morlet, 3.5 cycles) and absolute spectra normalization was firstly applied at single trial level 
(Grandchamp et al., 2012) for a baseline included in the time range between -400 ms and -100 ms. 
Finally, non-significant activity is set to zero (green) using bootstrap statistic method (α<0.05, 
number of permutations = 500) with respect to baseline. As in Pigorini et al. (2015), we calculated 
for each electrode the mean value of the event-related spectral perturbation (ERSP) above 20 Hz 
over a time-window ranging between − 350 and + 350 ms. Then, the average between 100 and 
350ms was carried out in order to quantify the high frequency power suppression. 
In order to calculate TMS time-locked activity and compare the duration of the deterministic effects 
of TMS, PLF was calculated as in Pigorini et al. (2015) across trials after high pass filtering (>8 Hz, 
Butterworth, 3rd order). Specifically, PLF was calculated as the absolute value of the average of 
the Hilbert transform of all single trials. Statistical differences from baseline (from -400 ms to -50 
ms) were assessed (for each channel) by assuming a Rayleigh distribution of the values of the 
baseline. Then, given a statistical threshold set at α<0.05, those PLF values below threshold were 
set to zero. In the case of evoked potentials, PLF reflects the ability of an external stimulus to affect 
the phase of ongoing oscillations across trials.  
Results 
Overall, we performed 212 TMS/EEG measurements in 21 patients and 33 healthy subjects using 
a TMS-compatible 60-channels EEG amplifier. Specifically, for each subject/patient we performed 
up to 9 TMS/EEG measurements in which cortical areas in the parietal or the in the frontal lobe 
were targeted and stimulated at 120 V/m. In total, 86 TMS/EEG measurements were included in 
the present study. For each session we consider the 4 channels closest to the stimulation site. 
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TMS/EEG recordings were analyzed in the frequency domain both for power and phase 
parameters (see Materials and Methods). 
In vegetative state patients TMS triggers a simple EEG response associated with a 
suppression of high-frequency oscillations and a short-lasting PLF 
Fig. 3.2.1 displays a typical EEG response to TMS of the right premotor cortex in an awake healthy 
subject (left side of panels A and B). As shown in previous works, this response is composed by a 
series of several positive and negative deflections corresponding to different voltage scalp 
topographies that initially involve the stimulation site (right premotor) and then other cortical 
locations (Massimini et al., 2005b; Rosanova et al., 2009). On the contrary, the TMS applied over 
the premotor cortex in an awake VS patient is characterized by a simple, large positive-negative 
deflection (right side of panels A and B) (Rosanova et al., 2012) that remains local.  
Notably, time-frequency analysis reveals a widespread and long-lasting increase of power for 
broadband (8-45 Hz) EEG oscillations triggered by TMS in healthy wakefulness, while in awake VS 
condition TMS evokes an early increase of power immediately followed by a significant 
suppression in the same frequency range (8-45 Hz)(left side of panel C). EEG scalp topographies 
of time-frequency power values cumulated between 8 and 45 Hz reveal that, after a global 
activation, this phenomenon has a very precise spatial distribution confined under the coil (right 
side of panel C).  
In order to quantify and compare the duration of the deterministic effects of TMS in both awake 
healthy subjects and awake VS patients, we calculated PLF of TMS-evoked potentials in the 8-45 
Hz frequency band as in Pigorini et al. (2015). Figure 3.2.1D shows that TEPs recorded in VS 
patients were characterized by an early drop (about 200 ms) of PLF below the level of statistical 
significance (Rayleigh, α<0.05) despite the recovery of high-frequency EEG power (>20 Hz) at the 
baseline level (right side of panel D). In fact, in awake healthy subjects TEPs show a significant 
PLF lasting up to 430 ms in the same frequency interval (left side of panel D) 
 
89 
 
 
Figure 3.2.1 – Comparison of TMS-evoked responses, time-frequency power spectra and PLF time course 
obtained during wakefulness in healthy subjects and in vegetative state patients: TMS evokes a stereotypical 
slow-wave-like response that is associated with high-frequency suppression followed by a drop of PLF in VS 
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patients but not in healthy subjects. A representative healthy subject (HC - Left) and a representative vegetative 
state patient (VS - Right) are shown.  
Panel A. Structural MRIs (T1-weighted) and cortical TMS target as estimated by NBS. 
Panel B. TMS-evoked cortical responses (the dashed vertical line indicates the onset of the TMS pulse). The 
grey traces show the butterfly plot of the superimposed averaged TMS-evoked responses recorded from all 60 
channels; the black trace represents the evoked potential recorded at one of the selected four electrode under 
the coil. Instantaneous voltage topographies at selected peaks are shown in the lower part of the panel (auto-
scaled color-coded maps between the maximum and the minimum of instantaneous voltages): of note, in the 
VS, the stimulus-evoked response remains local while, in the HC, the TMS stimulus results in a complex pattern 
of activation which initially involves the stimulation site and then spreads to other cortical areas.  
Panel C. Time-frequency power spectra of TMS-evoked potentials. For time-frequency decomposition, the 
Wavelet Transform (Morlet, 3.5 cycles) has been applied at a single trial level. Significance for bootstrap 
statistics is set at α<0,05 (absence of any significant activations is green-colored): red color indicates a 
significant power increase compared to the baseline, while blue color represents a significant power decrease. 
The dashed horizontal lines mark the 20 Hz frequency. 
In the lower part of the panel, the corresponding power topographies are depicted and subdivided in two main 
frequency bands, respectively a lower (from 8 to 20 Hz) and a higher band (from 20 to 45 Hz) (auto-scaled color-
coded maps between the maximum and the minimum of power). In the awake healthy subject, the TMS-related 
global power increase, for both bands, is typically sustained in time, whereas in the awake VS patient, an initial 
global power increase is replaced by a rapid power decrease followed by a recovery of the high frequency band 
(20-45 Hz) to the baseline level at the stimulation site. Conversely the power suppression of the low frequency 
band (8-20 Hz) persists over time up to 400-500 msec.  
Panel D. PLF-time course calculated on a single trial level after high-pass filtering (>8 Hz). To assess for each 
electrode the statistical difference from the baseline (from -500 to – 100 ms) a Rayleigh distribution of the 
baseline values was assumed. Then, those PLF values below a statistical threshold (α<0,01) were set to zero. In 
the lower part of the panel, the corresponding PLF topographies are depicted. Of note, in the VS patient, the PLF 
is short-lasting and sharply drops below the significance level concurrently with the high-frequency power 
suppression (see panel C), whereas in healthy subjects the global PLF activity is long-lasting and remains 
significant until ~400 ms. 
 
Figure 3.2.2A shows significant differences at the group level (Wilcoxon ranksum test, p<0.01) 
obtained for power in the low frequency range (<4 Hz) corresponding to spontaneous EEG delta 
waves, high-frequency EEG power suppression and duration of PLF (>8 Hz). These results show 
that across VS patients TMS/EEG cortical responses were characterized by a larger power in low 
frequency band (<4 Hz), by a significant suppression of high-frequency EEG activity (20-45 Hz) 
and by an early drop (~175 ms) of PLF. On the other hand, TMS delivered in awake healthy 
subjects evokes complex, sustained increase of power of the EEG responses in high-frequency 
and a PLF that remains significant until ~250 ms after the TMS pulse. Interestingly, as shown in 
Figure 3.2.2B, in VS patients the correlation between the maximum amplitude of the evoked slow 
wave (max SWa) and the maximum level of suppression of high frequency power (max SHFp) 
were significantly correlated. Similarly, also the latency at which PLF drops below the statistical 
significance level (max PLFt) and the timing of the maximum high frequency suppression (max 
SHFt). These correlations  strongly suggest that a larger TMS-evoked slow wave corresponds to a 
deeper suppression of high frequencies. Moreover, the earlier this suppression occurs the earlier 
the PLF drops down. 
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Figure 3.2.2 - Panel A. Differences at the group level between awake HC and VS patients. Slow wave amplitude 
(SWa<4 Hz), high frequency power (PWR>20 Hz) and duration of PLF (>8 Hz) between HC (red column) and VS 
patients (blue column) are significantly different (p<0.01). The three measures are calculated on the average 
across the four channels closest to the stimulation site. For each individual, SWa is calculated as the sum of the 
absolute value of the filtered (4 Hz low-pass, third order Chebyshev filtering) TMS-evoked response between 8 
and 350 ms after re-referencing to the mathematically linked mastoids. PWR is the mean power of high 
frequency (>20Hz) between 100 and 350 ms. The duration of PLF of frequencies above 8Hz is computed from the 
latest statistically significant time point and averaged across the four selected electrodes. Histograms indicate 
the average values between subject in each group (awake HC and VS), the black bars indicate the standard error 
of the mean and the asterisk * denotes the statistical significant differences (Wilcoxon ranksum test, p<0.01). 
Panel B. Amplitude, power and phase-locking modulation are related in VS patients. The correlation between the 
maximum amplitude of the evoked slow wave (max SWa) and the maximum level of high-frequency power 
suppression with respect to baseline (max SHFp) computed in each patient is shown on the left. The correlation 
between the timing of the maximum high frequency suppression (max SHFt) and the latency at which PLF fell 
below the threshold for significance (max PLFt) computed in each patient is shown on the right. Below each 
correlation, the coefficient of determination R2 and the significance level p of the correlation are indicated. 
TEPs in vegetative state and NREM sleep are similar in terms of waveform and spectral 
properties 
TEPs recorded in awake VS patients closely resemble EEG responses to TMS recorded during 
NREM sleep in healthy subjects (Rosanova et al., 2012). In order to further characterize this 
similarity we have performed TMS/EEG measurements in a subset of healthy controls (HC) during 
NREM sleep (stage N3). Figure 3.2.3A confirms that TMS evokes similar responses in awake VS 
patients and in healthy subjects during NREM sleep in terms of waveforms. However, time-
frequency analysis shows that the high-frequency EEG suppression associated with the negative 
phase of the wave is smaller in NREM sleep compared to VS. Furthermore, in NREM sleep this 
high- frequency suppression is followed by an increase of power in the frequency range of the 
sleep spindles that occurs, as expected, during the rising phase of the wave. Interestingly, as 
shown in Figure 3.2.3B, baseline power spectra (PWRb) above 20 Hz (average of single trial 
baseline from -600 to -100 ms) are significantly different, although the comparison of high-
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frequency suppression calculated in VS patients and healthy subjects in NREM sleep does not 
result in a statistically significant difference. 
 
Figure 3.2.3 – Panel A. Comparison of TMS-evoked potentials and time-frequency analyses between VS patients 
during wakefulness and healthy subjects during NREM sleep and wakefulness.  
The TMS-evoked cortical responses of three representative individuals in each condition are shown (top panel). 
As in figure 3.2.1, the grey traces represent the butterfly plot of TMS-evoked responses from all 60 channels; in 
each condition (awake VS patients  in blue, healthy subjects during NREM sleep in green and awake healthy 
subjects in red), the colored traces show the evoked potential recorded at the channel closest to the stimulation. 
On the bottom, the corresponding time-frequency analyses of the selected channels are shown. Despite the 
similar positive-negative slow wave evoked by the TMS, awake VS patients are characterized by a greater and 
more prolonged high-frequency EEG suppression compared to the NREM sleep of healthy subjects. Specifically, 
even if both conditions present a suppression of high frequencies (>20Hz) following the initial global power 
increase, in the VS patients the power reduction slowly recovers to the baseline whereas in the NREM sleep of 
healthy subjects it is replaced by a late increase of power. 
Panel B. Group-level comparison of the high-frequency mean power computed during the pre-stimulus (baseline 
spectra) and post-stimulus period in the three conditions (same color-coding of panel A). Both computations 
(baseline and post-stimulus) are performed, in each individual, on the same four channels closest to the 
stimulation site. The top histograms represent the mean of normalized spectra (PWRb) above 20 Hz obtained 
applying Fast Fourier Transform on the baseline (from -600 to -100 ms) The bottom histograms represent the 
mean of high-frequency power (PWR>20 Hz) from 100 and 350 ms.  
Resurgence of consciousness is paralleled by a recovery of TMS-evoked high-frequency 
oscillations and by a longer PLF 
Finally, we wanted to understand whether the suppression in TMS-evoked high frequency 
oscillations would be possibly modulated in those VS patients who spontaneously recover 
consciousness. To this aim, we longitudinally monitored by means of TMS/EEG 2 VS patients who 
progressively evolved through the Minimally Conscious State (MCS) and eventually regain 
consciousness. As shown in figure 3.2.4A, in these patients, TMS/EEG responses recorded at 
different stages of the clinical evolution were characterized by a progressive recovery of TMS-
evoked EEG high-frequency oscillations and by an increase of PLF duration. 
In figure 3.2.4B, VS patients are compared with MCS and HC subjects in terms of PWRb>20 Hz, 
SWa<4 Hz, PWR>20 Hz and duration of PLF. PWRb and SWa values are comparable between 
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VS and MCS patients, while the two groups differ in terms of EEG high-frequency suppression and 
PLF. On the contrary, PLF duration is similar between HC and MCS conditions. 
 
Figure 3.2.4 – Panel A. Longitudinal TMS-EEG evaluations in a single patient who gradually recovered 
consciousness evolving from a vegetative state (VS), through a minimally conscious state (MCS) to emergence 
from a MCS (EMCS). The butterfly plot of the TMS-evoked potentials, the corresponding time-frequency analysis 
and the PLF time course in each clinical status (VS, MCS and EMCS) are shown. TMS/EEG responses are 
characterized by a progressive recovery of high-frequency EEG power and by a parallel increase of the PLF 
duration which closely match the clinical evolution of the patient as assessed by the Coma Recovery Scale-
Revised (CRS-R). 
Panel B. Group-level comparison of high frequency baseline spectra (PWRb), slow wave amplitude (SWa), post-
stimulus high-frequency power (PWR) and duration of PLF (PLF) between VS patients (in blue), MCS patients (in 
yellow) and healthy subjects (in red). For computation details, refer to previous figures. Statistically significant 
differences are depicted by an the asterisk * (Wilcoxon rank sum test, p<0.01). 
Discussion 
In the work presented in this paragraph we compared TMS/EEG response recorded in awake 
severely brain-injured patients affected by disorders of consciousness and healthy subjects during 
NREM sleep and wakefulness by means of time-frequency analysis and PLF. We observed that 
while during wakefulness different cortical areas react to TMS with a pattern of activation which 
has a characteristic shape and frequency content and a sustained phase-locked response, in 
vegetative state patients TMS evokes a simple positive-negative wave and a cortical OFF-period 
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followed by a drop of phase-locking, similarly to healthy subjects during NREM sleep. Moreover, 
two patients who evolved from vegetative state to minimally conscious state, and emerged from 
minimally conscious state show a progressive recovery of EEG high frequency power and an 
increase of PLF duration, closely matching their clinical evolution. 
Bistability, cortical down-states and break-off of phase locked responses in VS patients 
TMS/EEG has been employed to measure cortical responses in healthy subjects as controls (HC) 
during wakefulness and at the bedside of awake VS/UWS patients. Coma Recovery Scale-Revised 
(CRS-R) has been performed 4 times a week, every other day, to minimize the possibility of a 
misdiagnosis due to fluctuations in behavioral responsiveness. In line with Rosanova et al 2009 
and 2012, the EEG response to TMS in HC during wakefulness resulted in complex activity 
patterns depending on the area stimulated, but in a local, stereotypical positive-negative wave in 
awake VS patients. We observed that this slow wave was associated with an OFF-period, possibly 
reflecting the neuronal down-state observed in animal intracellular (Steriade et al., 2001) and 
human intracranial (Cash et al., 2009; Pigorini et al., 2015) recordings during NREM sleep, 
suggesting that also in the case of pathological LOC bistability may play a role. These studies have 
shown that both spontaneous EEG sleep slow waves and K-complexes are underpinned by the 
occurrence of a silent, hyperpolarized down-state in cortical neurons, which is preceded and 
followed by a period of activation (up-state). This bimodal alternation between up- and down-states 
reflects an intrinsic bistability in thalamocortical circuits that is thought to depend on neuronal as 
well as network properties (Hill and Tononi, 2005; Mann et al., 2009; Sanchez-Vives and 
McCormick, 2000; Timofeev et al., 2000). During NREM sleep, bistability may be mainly caused by 
increased activity of leak K+ channels, brought about by decreased brainstem cholinergic activity 
(McCormick et al., 1993). On the other hand, increased inhibition within thalamocortical networks 
may play a crucial role in inducing bistability (Mann et al., 2009). Similarly, in brain injured patients 
brain lesions themselves may indirectly induce bistability in intact cortical tissue in several ways 
such as by (i) impairing the function of brainstem activating systems, thus enhancing K+-
conductances at the cortical level (Englot et al., 2010), by (ii) reducing the excitatory drive of 
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thalamostriatal circuits on cortical neurons (Schiff, 2010), by (iii) altering the excitation/inhibition 
balance in favor of inhibition (Murase et al., 2004), and by (iv) severing subcortical white matter 
fibers (Timofeev et al., 2000). In all cases, brain lesion may induce cortical bistability to various 
extents. The presence of an evoked slow wave associated with high frequency EEG suppression 
shown here in VS patients seems to confirm this possibility. A challenging relevant scientific 
question is then regarding the effects of such cortical dynamics on the overall brain complexity and 
in turn of the ability to sustain consciousness. Our proposition, is that following brain injury, due to 
bistability intact portions of thalamo-cortical system would not be able to sustain long-range 
patterns of causal activations in response to a direct stimulation. In order to verify this hypothesis 
we first performed a set of controlled experiments exploiting NREM sleep as a model to 
demonstrate a specific role of the down-state in the early disruption of causal cortico-cortical 
interaction following direct stimulation (see chapter 3.1, Pigorini et al., 2015). In brief, at odds with 
wakefulness during NREM sleep due to bistability cortical circuits, upon receiving an input, tend to 
respond briefly (thus showing the preserved reactivity of the sleeping brain) but then hush and 
forget. Specifically, PLF values dropped below significance after the occurrence of an OFF-period. 
Notably, the timing of occurrence of the OFF-period was correlated with the timing of the drop of 
PLF (see figure 3.1.2). Similarly, here we show that in awake VS patients the occurrence of TMS 
evoked OFF-periods was associated with an early drop of causal cortico-cortical interactions as 
reflected by short PLF durations as compared to wakefulness. More importantly, also in the case of 
awake VS patients the timing of the drop PLF was correlated with the occurrence of the OFF-
period thus providing for the first time a mechanistic account for the collapse of long-range causal 
cortico-cortical interaction following brain injury. 
Altogether these results suggest that in both physiological and pathological states consciousness 
may be impaired due to the occurrence of a silent OFF-period disrupting the emergence of long-
range causal brain dynamics. In order to demonstrate the causal role of bistability in the loss of 
consciousness following brain injury one should demonstrate that a reduction of TMS evoked slow 
waves and the associated down-states would follow the clinical progression towards the recovery 
of consciousness and that this is paralleled by a recovery of long-range causal interaction. Here we 
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explicitly addressed this account and performed longitudinal TMS/EEG measurements in brain 
injured patients who gradually recovered consciousness evolving from a vegetative state, through 
a minimally conscious state (MCS) to emergence from a MCS (EMCS). Our results showed a 
progressive reduction of the TMS evoked slow wave accompanied by a progressive recovery of 
high-frequency EEG power and by a parallel increase of the PLF duration (matching that off HC) 
which closely followed the clinical evolution of the patient as assessed by the Coma Recovery 
Scale-Revised (CRS-R). 
Brain complexity is related with high frequency EEG power suppression in VS patients 
This set of empirical evidences regarding the mechanism responsible for the collapse of long-
range causal interactions during LOC may also partially explain the collapse of brain complexity (a 
theoretically relevant aspect for consciousness) across different conditions such as sleep, 
anesthesia and VS following severe brain injury, as measured by PCI (Casali et al., 2013). Indeed, 
PCI captures the complexity of the spatiotemporal pattern of deterministic activation following a 
direct perturbation. As such the overall brain complexity should be low during LOC conditions due 
to the occurrence of a silent OFF-periods that breaks-off causal cortico-cortical interactions 
therefore preventing the emergence of complex large-scale deterministic activations. In an attempt 
to illustrate this possibility here we perform preliminary analysis correlating the timing of the 
occurrence of the evoked OFF-period with the temporal evolution of PCI. Interestingly, we found a 
significant positive correlation showing that build-up of algorithmic complexity ceased to occur soon 
after the occurrence of the evoked OFF-period. Far from been conclusive these results highlight 
the tight link between a basic neurophysiological mechanism (i.e. bistability) and a theoretically 
based index of consciousness. 
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Figure 3.2.5 – Panel A. TMS-evoked cortical responses (top of the panel, a selected channel in bold) of a 
representative VS patient and a representative healthy subject, the time-frequency analysis of the 
corresponding bold channel (middle of the panel), and the temporal evolution of PCI (bottom of the panel) are 
shown. In the bottom graphs representing the time course of PCI, the light-dashed vertical line marks the exact 
time when PCI reach the 99% (t(99%PCI)) of its maximum value (indicated by a number at the end of each 
temporal evolution) while the light-dashed horizontal line indicates the corresponding 99% of PCI value. Panel 
B. On the left, the temporal evolution of PCI, PCI(t), calculated during wakefulness (light-red lines) and 
pathological loss of consciousness (light-blue lines) at the single-subject level. The dark blue and red lines 
represent averaged PCI(t). In the middle of the panel, the group-level comparison of t(99%PCI) computed in VS 
patients (blue column) and healthy subjects (red column) shows that they are significantly different (Wilcoxon 
ranksum test, p<0.01). On the right, the correlation between the time of the maximum high frequency 
suppression (max SHFt) and the time (t(99%PCI)) when PCI reach the 99% of its maximum value. The 
relationship between the two time measures could indicate that the occurrence of an OFF-period can prevent 
the further growing of PCI. The coefficient of determination R2 and the significance p level are reported.  
 
Following these lines of evidence, further studies should aim at deepening the understanding of the 
cellular/molecular aspects of such mechanisms since bistability is in principle reversible and may 
represent a suitable pharmacological target for novel therapeutic approaches aimed at promoting 
brain complexity and in turn recovery of consciousness following brain injury.  
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